<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction - Silva, V - 2019 | Cochrane Library</title> <meta content="Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction - Silva, V - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012044.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction - Silva, V - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012044.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012044.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction" name="citation_title"/> <meta content="Valter Silva" name="citation_author"/> <meta content="Centro Universitário Tiradentes (UNIT/AL)" name="citation_author_institution"/> <meta content="v.silva@ymail.com" name="citation_author_email"/> <meta content="Antonio Jose Grande" name="citation_author"/> <meta content="Universidade Estadual de Mato Grosso do Sul" name="citation_author_institution"/> <meta content="Maria S Peccin" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD012044.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/04/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012044.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012044.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012044.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Exercise [*physiology]; Lower Urinary Tract Symptoms [*etiology, *therapy]; Prostatic Hyperplasia [*complications, therapy]; Randomized Controlled Trials as Topic; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012044.pub2&amp;doi=10.1002/14651858.CD012044.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012044\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012044\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","fr","th","de","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012044.pub2",title:"Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction",firstPublishedDate:"Apr 6, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Urology Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012044.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012044.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012044.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012044.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012044.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012044.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012044.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012044.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012044.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012044.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3565 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012044.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0160"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0079"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-sec-0154"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/appendices#CD012044-sec-0165"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/table_n/CD012044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/table_n/CD012044StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#CD012044-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Valter Silva</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#CD012044-cr-0003">Antonio Jose Grande</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information#CD012044-cr-0004">Maria S Peccin</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information/en#CD012044-sec-0174">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 April 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012044.pub2">https://doi.org/10.1002/14651858.CD012044.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012044-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012044-abs-0013">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012044-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012044-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012044-abs-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012044-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012044-abs-0001" lang="en"> <section id="CD012044-sec-0001"> <h3 class="title" id="CD012044-sec-0001">Background</h3> <p>Lower urinary tract symptoms caused by benign prostatic obstruction (LUTS/BPO) represents one of the most common clinical complaints in men. Physical activity might represent a viable first‐line intervention for treating LUTS/BPO. </p> </section> <section id="CD012044-sec-0002"> <h3 class="title" id="CD012044-sec-0002">Objectives</h3> <p>To assess the effects of physical activity for lower urinary tract symptoms caused by benign prostatic obstruction (LUTS/BPO). </p> </section> <section id="CD012044-sec-0003"> <h3 class="title" id="CD012044-sec-0003">Search methods</h3> <p>We performed a comprehensive search of multiple databases (CENTRAL, MEDLINE, Embase, Web of Science, LILACS, ClinicalTrials.gov, and WHO ICTRP); checked the reference lists of retrieved articles; and handsearched abstract proceedings of conferences with no restrictions on the language of publication or publication status from database inception to 6 November 2018. </p> </section> <section id="CD012044-sec-0004"> <h3 class="title" id="CD012044-sec-0004">Selection criteria</h3> <p>We included published and unpublished randomised controlled and controlled clinical trials that included men diagnosed with LUTS/BPO. We excluded studies in which medical history suggested non‐BPO causes of LUTS or prior invasive therapies to physical activity or that used electrical stimulation. </p> </section> <section id="CD012044-sec-0005"> <h3 class="title" id="CD012044-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study eligibility, extracted data, and assessed the risk of bias of included studies. We assessed primary outcomes (symptom score for LUTS; response rate, defined as 20% improvement in symptom score; withdrawal due to adverse events) and secondary outcomes (change of medication use; need for an invasive procedure; postvoid residual urine). We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD012044-sec-0006"> <h3 class="title" id="CD012044-sec-0006">Main results</h3> <p>We included six studies that randomised 652 men over 40 years old with moderate or severe LUTS. The four different comparisons were as follows: </p> <p><b>Physical activity versus watchful waiting</b> </p> <p>Two RCTs randomised 119 participants. The interventions included tai chi and pelvic floor exercise. The evidence was overall of very low quality, and we are uncertain about the effects of physical activity on symptom score for LUTS (mean difference (MD) ‐8.1, 95% confidence interval (CI) ‐13.2 to ‐3.1); response rate (risk ratio (RR) 1.80, 95% CI 0.81 to 4.02; 286 more men per 1000, 95% CI 68 fewer to 1079 more); and withdrawal due to adverse events (RR 1.00, 95% CI 0.59 to 1.69; 0 fewer men per 1000, 95% CI 205 fewer to 345 more). </p> <p><b>Physical activity as part of self‐management programme versus watchful waiting</b> </p> <p>Two RCTs randomised 362 participants. Pelvic floor exercise was one of multiple intervention components. The evidence was of very low quality, and we are uncertain about the effects of physical activity for symptom score for LUTS (MD ‐6.2, 95% CI ‐9.9 to ‐2.5); response rate (RR 2.36, 95% CI 1.32 to 4.21; 424 more men per 1000, 95% CI 100 more to 1000 more); and withdrawal due to adverse events (risk difference 0.00, 95% CI ‐0.05 to 0.06; 65 fewer men per 1000, 95% CI 65 fewer to 65 fewer). </p> <p><b>Physical activity as part of weight reduction programme versus watchful waiting</b> </p> <p>One RCT randomised 130 participants. An unclear type of intense exercise was one of multiple intervention components. The evidence was of very low quality, and we are uncertain about the effects for symptom score for LUTS (MD ‐1.1, 95% CI ‐3.5 to 1.3); response rate (RR 1.20, 95% CI 0.74 to 1.94; 67 more men per 1000, 95% CI 87 fewer to 313 more); and withdrawal due to adverse events (RR 1.63, 95% CI 1.03 to 2.57; 184 more men per 1000, 95% CI 9 more to 459 more). </p> <p><b>Physical activity versus alpha‐blockers</b> </p> <p>One RCT randomised 41 participants to pelvic floor exercise or alpha‐blockers. The evidence was of very low quality, and we are uncertain about the effects for symptom score for LUTS (MD 2.8, 95% CI ‐0.9 to 6.4) and response rate (RR 0.80, 95% CI 0.55 to 1.15; 167 fewer men per 1000, 95% CI 375 fewer to 125 more). The evidence was of low quality for withdrawal due to adverse events; the effects for this outcome may be similar between interventions (RR 0.86, 95% CI 0.06 to 12.89; 7 fewer men per 1000, 95% CI 49 fewer to 626 more). </p> </section> <section id="CD012044-sec-0007"> <h3 class="title" id="CD012044-sec-0007">Authors' conclusions</h3> <p>We rated the quality of the evidence for most of the effects of physical activity for LUTS/BPO as very low. We are therefore uncertain whether physical activity affects symptom scores for LUTS, response rate, and withdrawal due to adverse events. Our confidence in the estimates was lowered due to study limitations, inconsistency, indirectness, and imprecision. Additional high‐quality research is necessary. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012044-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012044-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012044-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012044-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012044-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012044-abs-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012044-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012044-abs-0005" lang="en"> <h3>Physical activity for lower urinary tract symptoms due to benign prostatic obstruction</h3> <p><b>Review question</b> </p> <p>What are the effects of physical activity on lower urinary tract symptoms in men with an enlarged prostate? </p> <p><b>Background</b> </p> <p>As men grow older, many develop bothersome urinary problems, such as a weak stream and frequent urination during the day or nightime. A common reason for these symptoms is enlargement of the prostate. Treatment for this problem includes lifestyle changes (like drinking less fluid), medications, and surgical procedures. Physical activity, defined as movement produced by muscles, may also improve these symptoms. We conducted this review to compare how physical activity compares to other methods, in treating such urinary tract symptoms. </p> <p><b>Study characteristics</b> </p> <p>We included six studies, comprising 652 men altogether, that studied four different comparisons. The studies compared different forms of physical activity, alone or as part of a self‐management programme, to watchful waiting (no specific intervention) or to alpha‐blocker treatment. </p> <p>Based on very low‐quality evidence for the outcomes of symptom score for lower urinary tract symptoms, and stopping the treatment because of unwanted effects, we are uncertain whether physical activity interventions are helpful in men with lower urinary tract symptoms due to benign prostatic obstruction. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence was very low, which means that the true effect may be substantially different from the findings of the review. Further research is very likely to change the results. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012044-sec-0160" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-sec-0160">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-sec-0225">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012044-sec-0160"></div> <h3 class="title" id="CD012044-sec-0161">Implications for practice</h3> <section id="CD012044-sec-0161"> <p>Patients, healthcare providers, and healthcare policymakers considering the use of physical activity for lower urinary tract symptoms due to benign prostatic obstruction (LUTS/BPO) should recognise that the evidence for the effectiveness and safety of the intervention is considered to be of very low quality. We are uncertain of the effects of physical activity on symptom score for LUTS, response rate, and withdrawal due to adverse events. Our confidence in the estimates was lowered due to study limitations, inconsistency, indirectness, and imprecision. </p> </section> <h3 class="title" id="CD012044-sec-0162">Implications for research</h3> <section id="CD012044-sec-0162"> <p>The studies included in this review have important methodological limitations that compromise the quality of the evidence of the findings. Additional high‐quality trials are needed to enable a more definitive conclusion. We encourage future research to produce evidence towards the following: </p> <p> <ul id="CD012044-list-0020"> <li> <p>Comparative effectiveness of physical activity for LUTS/BPO versus several other comparison interventions, in particular with therapies that are already well established (e.g. 5‐alpha reductase inhibitors, combination therapy, invasive therapies) should be assessed. </p> </li> <li> <p>Different types of physical activities need to be compared, since efficacy and safety can be affected. Adherence may be influenced by the type of physical activity and how it is delivered, impacting on effects of intervention; e.g. walking, gym, aquatic activities, or group activities might have better adherence than running, cycling, or individual activities. </p> </li> <li> <p>Efficacy, safety, and adherence can also be changed due to different intensities (light, moderate, and vigorous), frequencies (day/week), and volumes (min/day) of physical activities. These comparisons can help answer the dose needed to produce benefits safely. </p> </li> <li> <p>Multimodal therapeutic trials, such as those applying the self‐management programme, may use multiple intervention groups to compare more than two interventions (e.g. pelvic floor exercise versus education versus medication versus all interventions together). </p> </li> <li> <p>Multicentre pragmatic cluster‐randomised controlled trials would be helpful. A pragmatic trial would assess real‐world applicability of the intervention; e.g. in the experimental group, different types of physical activity can be used, while various intensities, frequencies, and volumes, and physical activity can be combined with other interventions. Multicentre cluster randomisation can reduce the potential for contamination between interventions being delivered within a single clinical site with the potential for subversion of the protocol. </p> </li> </ul> </p> <p>Additionally, future studies should be better designed and reported as follows:</p> <p> <ul id="CD012044-list-0021"> <li> <p>Avoid biased allocation to interventions by using adequate methods (e.g. central allocation; sequentially numbered, opaque, sealed envelopes). </p> </li> <li> <p>Blind as many individuals as possible in the trial. Although participants cannot be blinded, it is possible to blind practitioners who will deliver the intervention, outcome assessors, and data analysts. </p> </li> <li> <p>Use intention‐to‐treat analysis and avoid per‐protocol analysis. It is important that all randomised participants be included adequately in the final analysis. </p> </li> <li> <p>Register the study protocol, avoiding protocol deviations and violations and reporting all outcomes. </p> </li> <li> <p>Use a long‐term duration intervention (12 months or more), continuing the follow‐up after the intervention is stopped. </p> </li> <li> <p>Use an adequate sample size.</p> </li> <li> <p>Properly report baseline characteristics.</p> </li> <li> <p>Adequately report physical activity, i.e. intervention delivery, type of physical activity, intensity, frequency, and volume. </p> </li> <li> <p>Transparent reporting of results to allow independent confirmation of all analyses and also acknowledging study limitations. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012044-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012044-sec-0043"></div> <div class="table" id="CD012044-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Physical activity compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (tai chi and pelvic floor exercise) </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was 17.1 (95% CI 11.9 to 22.3).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.1 lower<br/> (13.2 lower to 3.9 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.80<br/> (0.81 to 4.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>357 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286 more per 1000<br/> (68 fewer to 1000 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b> </p> <p>Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.59 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 fewer per 1000<br/> (205 fewer to 345 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); blinding of participants and personnel (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>); incomplete outcome data (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); other bias (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>2</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>).<br/> <sup>3</sup>Downgraded for imprecision (‐1): wide confidence interval; small sample size; low event rates—only one small study (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; n = 28) contributed with data and analyses.<br/> <sup>4</sup>Dowgraded for imprecision (‐1): wide confidence interval; small sample size; low event rates.<br/> <sup>5</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); incomplete outcome data (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); other bias (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>6</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>7</sup>Dowgraded for imprecision (‐1): small sample size; low event rates. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012044-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Physical activity as part of self‐management programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (pelvic floor exercise) as part of self‐management programme </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity as part of self‐management programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b> </p> <p>Assessed with: IPSS<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS by IPSS was 17.8 (95% CI 16.7 to 18.8).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 6.2 lower<br/> (9.9 lower to 2.5 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b> </p> <p>Assessed with: frequency<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.36<br/> (1.32 to 4.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>424 more per 1000<br/> (100 more to 1000 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b> </p> <p>Assessed with: frequency<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 fewer per 1000<br/> (65 fewer to 65 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); blinding of participants and personnel (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>); blinding of outcome assessment (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); other bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>).<br/> <sup>2</sup>Downgraded for inconsistency (‐1): variation in point estimates; confidence intervals do not overlap; heterogeneity (I<sup>2</sup> = 87%; P = 0.005).<br/> <sup>3</sup>Downgraded for indirectness (‐1): pelvic floor exercise was one component of a complex intervention, thus we cannot attribute the effect to physical activity alone.<br/> <sup>4</sup>Dowgraded for imprecision (‐1): wide confidence interval; low event rates.<br/> <sup>5</sup>Downgraded for inconsistency (‐1): variation in point estimates; heterogeneity (I<sup>2</sup> = 83%; P = 0.01).<br/> <sup>6</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); selective reporting (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); other bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>).<br/> <sup>7</sup>Downgraded for imprecision (‐1): low event rates. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012044-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Physical activity as part of weight reduction programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (intense exercise) as part of weight reduction programme </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity as part of weight reduction programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 48 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was ‐0.7 (95% CI ‐2.4 to 1.0).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.1 lower<br/> (3.5 lower to 1.3 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 48 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>117<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.20<br/> (0.74 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 more per 1000<br/> (87 fewer to 313 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b><br/> Assessed with: frequency </p> <p>Follow‐up: 48 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>130<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.63<br/> (1.03 to 2.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184 more per 1000<br/> (9 more to 459 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>): blinding of participants and personnel; incomplete outcome data; selective reporting; other bias.<br/> <sup>2</sup>Downgraded for indirectness (‐2): physical activity was one component of a complex intervention; thus we cannot attribute the effect to physical activity alone; the intervention was described as "intense exercise", but there was insufficient information regarding type, frequency, and duration of physical activity.<br/> <sup>3</sup>Dowgraded for imprecision (‐1): low event rates.<br/> <sup>4</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>): incomplete outcome data; selective reporting; other bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012044-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Physical activity compared to alpha‐blockers for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (pelvic floor exercise) </p> <p><b>Comparison:</b> alpha‐blockers (tamsulosin 0.4 mg/day) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with alpha‐blockers</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was 8.8 (95% CI 5.9 to 11.7).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.8 higher<br/> (0.9 lower to 6.4 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/> (0.55 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>833 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>167 fewer per 1000<br/> (375 fewer to 125 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>41<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.06 to 12.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 fewer per 1000<br/> (49 fewer to 626 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>): blinding of participants and personnel; blinding of outcome assessment; selective reporting.<br/> <sup>2</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>).<br/> <sup>3</sup>Dowgraded for imprecision (‐1): small sample size; low event rates. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012044-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-sec-0184">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012044-sec-0044"></div> <p>We conducted this systematic review following the protocol previously published in the Cochrane Database of Systematic Reviews (<a href="./references#CD012044-bbs2-0072" title="SilvaV , GrandeAJ , StantonKR , PeccinMS . Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012044] ">Silva 2016</a>). For explanations of methodological terms, see the main glossary on the Cochrane website (<a href="http://community.cochrane.org/glossary" target="_blank">community.cochrane.org/glossary</a>). </p> <section id="CD012044-sec-0045"> <h3 class="title" id="CD012044-sec-0045">Description of the condition</h3> <p>Lower urinary tract symptoms (LUTS) caused by benign prostatic obstruction (BPO) (LUTS/BPO) represents one of the most common clinical complaints in men (<a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>; <a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>). Lower urinary tract symptoms comprise storage, voiding, and postmicturition symptoms (<a href="./references#CD012044-bbs2-0020" title="AbramsP , CardozoL , FallM , GriffithsD , RosierP , UlmstenU , et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub‐committee of the International Continence Society. Urology2003;61(1):37‐49. [DOI: 10.1016/S0090‐4295(02)02243‐4] ">Abrams 2003</a>; <a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>; <a href="./references#CD012044-bbs2-0050" title="International Continence Society. Terminology. www.ics.org/terminology (accessed 24 November 2017). ">ICS 2017</a>; <a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>). Storage symptoms include increased daytime frequency, nocturia, urgency, urinary incontinence (stress, urge, mixed, and continuous), overactive bladder, enuresis, and altered bladder sensation (<a href="./references#CD012044-bbs2-0050" title="International Continence Society. Terminology. www.ics.org/terminology (accessed 24 November 2017). ">ICS 2017</a>). Voiding symptoms include slow stream, splitting or spraying, intermittent stream (intermittency), hesitancy, straining, and terminal dribble (<a href="./references#CD012044-bbs2-0050" title="International Continence Society. Terminology. www.ics.org/terminology (accessed 24 November 2017). ">ICS 2017</a>). Postmicturition symptoms include a feeling of incomplete emptying and postmicturition dribble (<a href="./references#CD012044-bbs2-0050" title="International Continence Society. Terminology. www.ics.org/terminology (accessed 24 November 2017). ">ICS 2017</a>). Symptom scores (e.g. International Prostate Symptom Score (IPSS) and Danish Prostate Symptom Score (DAN‐PSS)) are the standard tool for assessing and monitoring male LUTS and identifying predominant symptom type (<a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>). </p> <p>Although the aetiology of male LUTS is multifactorial, BPO is recognised as a major cause and is the preferred target of treatment. A physiologic increase in the number of cells in the prostate, reduced rate of cell death, or both, can cause a hyperplastic epithelial and stromal growth coalescing into microscopic and macroscopic nodules and defining a nonneoplastic histologic pattern called benign prostatic hyperplasia (BPH). Benign prostatic enlargement (BPE) secondary to BPH, together with increased prostatic smooth muscle tone, can compress the urethra, leading to bladder outlet obstruction (BOO) and secondary LUTS (<a href="./references#CD012044-bbs2-0020" title="AbramsP , CardozoL , FallM , GriffithsD , RosierP , UlmstenU , et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub‐committee of the International Continence Society. Urology2003;61(1):37‐49. [DOI: 10.1016/S0090‐4295(02)02243‐4] ">Abrams 2003</a>; <a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>; <a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>; <a href="./references#CD012044-bbs2-0054" title="NicholsonTM , RickeWA . Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation; Research in Biological Diversity2011;82(4‐5):184‐99. [DOI: 10.1016/j.diff.2011.04.006] ">Nicholson 2011</a>; <a href="./references#CD012044-bbs2-0057" title="RoehrbornCG . Pathology of benign prostatic hyperplasia. International Journal of Impotence Research2008;20(3):S11‐8. [DOI: 10.1038/ijir.2008.55] ">Roehrborn 2008</a>; <a href="./references#CD012044-bbs2-0065" title="TangJ , YangJ . Etiopathogenesis of benign prostatic hyperplasia. Indian Journal of Urology2009;25(3):312‐7. [DOI: 10.4103/0970‐1591.56179] ">Tang 2009</a>). </p> <p>The prevalence of BPH by histologic approach is around 10% in men aged 30 to 39 years, 40% in men aged 40 to 59 years, 60% in men aged 60 to 69 years, 80% in men aged 70 to 79 years, and 90% in men aged 80 to 89 years old (<a href="./references#CD012044-bbs2-0057" title="RoehrbornCG . Pathology of benign prostatic hyperplasia. International Journal of Impotence Research2008;20(3):S11‐8. [DOI: 10.1038/ijir.2008.55] ">Roehrborn 2008</a>). Approximately 50% of all men aged 40 years or older who have a histologic diagnosis of BPH have moderate to severe LUTS (<a href="./references#CD012044-bbs2-0057" title="RoehrbornCG . Pathology of benign prostatic hyperplasia. International Journal of Impotence Research2008;20(3):S11‐8. [DOI: 10.1038/ijir.2008.55] ">Roehrborn 2008</a>). Benign prostatic obstruction occurs in 64% of men with LUTS (<a href="./references#CD012044-bbs2-0029" title="D'SilvaKA , DahmP , WongCL . Does this man with lower urinary tract symptoms have bladder outlet obstruction? The Rational Clinical Examination: a systematic review. JAMA2014;312(5):535‐42. [DOI: 10.1001/jama.2014.5555] ">D'Silva 2014</a>). As the worldwide population ages (men aged 60 years or over represented 7% of the global population in 1950 and 11% in 2015, a figure that could rise to 27% by 2100) (<a href="./references#CD012044-bbs2-0067" title="UnitedNations , Department of Economic and Social Affairs, PopulationDivision . World population prospects: the 2015 revision, key findings and advance tables. 2015. Working Paper No. ESA/P/WP.241. esa.un.org/unpd/wpp/ (accessed 18 August 2015). ">United Nations 2015</a>), the probability of new cases of LUTS/BPO will increase. Among the 10 most prevalent diseases in men aged 50 years or older, LUTS/BPO ranks as the seventh most frequently diagnosed and most costly; moreoever, with acute urinary retention or surgeries occurring in around 20% of cases, LUTS/BPO is the second most likely to trigger a significant clinical event within one year of initiating treatment (<a href="./references#CD012044-bbs2-0034" title="FenterTC , NaslundMJ , ShahMB , EaddyMT , BlackL . The cost of treating the 10 most prevalent diseases in men 50 years of age or older. American Journal of Managed Care2006;12(4 Suppl):S90‐8. [PUBMED: 16551207] ">Fenter 2006</a>). The direct cost of LUTS/BPO treatment in 2007 was estimated at USD 1.41 billion, including inpatient, hospital outpatient, ambulatory surgery, physician office, and emergency room visits (<a href="./references#CD012044-bbs2-0066" title="Urologic Diseases in America. Table 14‐10. Economic impact of urologic disease. In: Litwin MS, Saigal CS (editors). Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office, 2012; NIH Publication No. 12‐7865, pp. 463‐496. urology.ucla.edu/workfiles/Research/UDA_2012_Compendium.pdf (accessed 7 January 2015). ">UDA 2012</a>). Although LUTS/BPO is not often life threatening, it is associated with significant symptom burden and imposes high personal and societal costs (both direct and indirect) that negatively affect quality of life in men and their partners; therefore, its impact should not be underestimated (<a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>; <a href="./references#CD012044-bbs2-0062" title="SpeakmanM , KirbyR , DoyleS , IoannouC . Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) ‐ focus on the UK. BJU International2015;115(4):508‐19. [DOI: 10.1111/bju.12745] ">Speakman 2015</a>). </p> </section> <section id="CD012044-sec-0046"> <h3 class="title" id="CD012044-sec-0046">Description of the intervention</h3> <p>Treatment options for men with LUTS/BPO include the following (<a href="./references#CD012044-bbs2-0026" title="BrownCT , van derMeulenJ , MundyAR , O'FlynnE , EmbertonM . Defining the components of a self‐management programme for men with uncomplicated lower urinary tract symptoms: a consensus approach. European Urology2004;46(2):254–63. [DOI: 10.1016/j.eururo.2004.02.008] ">Brown 2004a</a>; <a href="./references#CD012044-bbs2-0033" title="EmbertonM . Patient‐led management of BPH: from watchful waiting to self‐management of LUTS. European Urology2006;5(12):704‐9. [DOI: 10.1016/j.eursup.2006.06.008] ">Emberton 2006</a>; <a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>; <a href="./references#CD012044-bbs2-0040" title="GravasS , BachT , BachmannA , DrakeM , GacciM , GratzkeC , et al. EAU Guidelines 2016: Treatment of non neurogenic male LUTS. uroweb.org/guideline/treatment‐of‐non‐neurogenic‐male‐luts/ (accessed 11 November 2016). ">Gravas 2016</a>; <a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>): </p> <p> <ul id="CD012044-list-0001"> <li> <p>Watchful waiting (also known as active surveillance, active monitoring, self‐management, or self‐care), a clinical management approach wherein usual treatment is delayed for a period of observation, during which disease progression is periodically monitored. Watchful waiting is generally employed for conditions that progress slowly or when the risks of treatment outweigh the potential benefits. Interventions can range from regular office visits to intensive, multidisciplinary, multimodal programmes that may include patient education, reassurance, counseling, lifestyle changes, and physical activity (e.g. pelvic floor exercise). </p> </li> <li> <p>Medical therapies, comprising single or combination drugs (e.g. alpha‐blockers and 5‐alpha reductase inhibitors (5‐ARIs)). </p> </li> <li> <p>Complementary therapies or alternative medicines (e.g. <i>Serenoa repens</i> , <i>Pygeum africanum</i>, or tai chi). </p> </li> <li> <p>Surgical therapies.</p> </li> </ul> </p> <p>The usual approach to care involves pharmaceutical and invasive interventions. Adverse events and effects associated with available therapeutic modalities (<a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>; <a href="./references#CD012044-bbs2-0040" title="GravasS , BachT , BachmannA , DrakeM , GacciM , GratzkeC , et al. EAU Guidelines 2016: Treatment of non neurogenic male LUTS. uroweb.org/guideline/treatment‐of‐non‐neurogenic‐male‐luts/ (accessed 11 November 2016). ">Gravas 2016</a>; <a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>) include the following: </p> <p> <ul id="CD012044-list-0002"> <li> <p>Alpha‐blockers: asthenia, dizziness, and (orthostatic) hypotension; falls and fractures (secondary to dizziness and hypotension); abnormal ejaculation (decreased or absent ejaculate volume); and intraoperative floppy‐iris syndrome. </p> </li> <li> <p>5‐alpha reductase inhibitors: reduced libido; erectile dysfunction; ejaculation disorders (retrograde ejaculation, ejaculation failure, or decreased semen volume); and gynaecomastia. </p> </li> <li> <p>Antimuscarinic drugs: dry mouth, constipation, micturition difficulties, nasopharyngitis, and dizziness. </p> </li> <li> <p>Phosphodiesterase type 5 inhibitors: flushing, gastroesophageal reflux, headache, dyspepsia, back pain, and nasal congestion. </p> </li> <li> <p>Beta‐3 agonists: hypertension, urinary tract infections, headache, and nasopharyngitis.</p> </li> <li> <p>Transurethral needle ablation of the prostate: mild haematuria, urinary tract infections, strictures, incontinence, erectile dysfunction, and ejaculation disorders. </p> </li> <li> <p>Laser treatments of the prostate: dysuria, urethral stricture, stress urinary incontinence, and reintervention. </p> </li> <li> <p>Prostatic stents: stent migration, exacerbation of LUTS, encrustation, perineal pain, and bladder storage symptoms. </p> </li> <li> <p>Prostatic urethral lift: haematuria, dysuria, pelvic pain, urgency, transient incontinence, and urinary tract infections. </p> </li> <li> <p>Minimally invasive simple prostatectomy: postoperative complication, haematuria requiring irrigation, urinary tract infections, ileus, and acute urinary retention. </p> </li> </ul> </p> <p>The frequency of adverse events was significantly higher for combination drug therapy.</p> <p>Physical activity appears to potentially be able to prevent and treat several health issues (<a href="./references#CD012044-bbs2-0037" title="GillespieLD , RobertsonMC , GillespieWJ , SherringtonC , GatesS , ClemsonLM , et al. Interventions for preventing falls in older people living in the community. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007146.pub3] ">Gillespie 2012</a>; <a href="./references#CD012044-bbs2-0048" title="HoweTE , SheaB , DawsonLJ , DownieF , MurrayA , RossC , et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD000333.pub2] ">Howe 2011</a>; <a href="./references#CD012044-bbs2-0053" title="MishraSI , SchererRW , SnyderC , GeiglePM , BerlansteinDR , TopalogluO . Exercise interventions on health‐related quality of life for people with cancer during active treatment. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD008465.pub2] ">Mishra 2012</a>). In the case of LUTS/BPO, physical activity could be an attractive first‐line and complementary option, since studies do not suggest that it is associated with adverse events (<a href="./references#CD012044-bbs2-0023" title="BarkinJ . Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Canadian Journal of Urology2011;18(1):14‐9. [PUBMED: 21501546] ">Barkin 2011</a>; <a href="./references#CD012044-bbs2-0030" title="DeNunzioC , AhyaiS , AutorinoR , BachmannA , BialekW , BrigantiA , et al. Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. European Urology2011;60(6):1205‐6. [DOI: 10.1016/j.eururo.2011.08.055] ">De Nunzio 2011</a>; <a href="./references#CD012044-bbs2-0031" title="DonnellRF . Benign prostate hyperplasia: a review of the year’s progress from bench to clinic. Current Opinion in Urology2011;21(1):22‐6. [DOI: 10.1097/MOU.0b013e32834100dd] ">Donnell 2011</a>; <a href="./references#CD012044-bbs2-0032" title="DumoulinC , Hay‐SmithJ , FrawleyH , McClurgD , AlewijnseD , BoK , et al. 2014 consensus statement on improving pelvic floor muscle training adherence: International Continence Society 2011 State‐of‐the‐Science Seminar. Neurourology and Urodynamics2015;34(7):600‐5. [DOI: 10.1002/nau.22796] ">Dumoulin 2015</a>; <a href="./references#CD012044-bbs2-0058" title="RussoGI , CastelliT , UrzìD , PriviteraS , LaVigneraS , CondorelliRA , et al. Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematic review. International Journal of Urology2015;22(11):982‐90. [DOI: 10.1111/iju.12877] ">Russo 2015</a>). </p> <p>Physical activity is defined as any bodily movement produced by skeletal muscles that requires energy expenditure, including occupational activities, daily activities, exercise, and sports (<a href="./references#CD012044-bbs2-0027" title="CaspersenCJ , PowellKE , ChristensonGM . Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research. Public Health Reports (Washington, DC: 1974)1985;100(2):126‐31. [PUBMED: 3920711] ">Caspersen 1985</a>). Intensity, frequency, and volume are important characteristics to take into consideration when implementing interventions of physical activities (<a href="./references#CD012044-bbs2-0021" title="AinsworthBE , HaskellWL ,  HerrmannSD ,  MeckesN , BassettDRJr , Tudor‐LockeC , et al. 2011 Compendium of physical activities: a second update of codes and MET values. Medicine and Science in Sports and Exercise2011;43(8):1575‐81. [DOI: 10.1249/MSS.0b013e31821ece12] ">Ainsworth 2011</a>; <a href="./references#CD012044-bbs2-0022" title="AinsworthBE , HaskellWL , HerrmannSD , MeckesN , BassettDRJr , Tudor‐LockeC , et al. The compendium of physical activities tracking guide. Healthy Lifestyles Research Center, College of Nursing &amp; Health Innovation, Arizona State University. sites.google.com/site/compendiumofphysicalactivities/home (accessed 7 May 2012). ">Ainsworth 2012</a>), particularly in the presence of a comorbidity such as LUTS/BPO (<a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>). Physical activity can be classified by metabolic equivalent of task (MET) as light intensity (1.6 to 2.9 METs), moderate intensity (3 to 5.9 METs), or vigorous intensity (6 or more METs). MET expresses the energy cost of physical activities, set by convention to 3.5 mL O<sub>2</sub>/kg per minute (equivalent to 1 kilocalorie/kg per hour or 4.184 kJ/kg per hour) (<a href="./references#CD012044-bbs2-0021" title="AinsworthBE , HaskellWL ,  HerrmannSD ,  MeckesN , BassettDRJr , Tudor‐LockeC , et al. 2011 Compendium of physical activities: a second update of codes and MET values. Medicine and Science in Sports and Exercise2011;43(8):1575‐81. [DOI: 10.1249/MSS.0b013e31821ece12] ">Ainsworth 2011</a>; <a href="./references#CD012044-bbs2-0022" title="AinsworthBE , HaskellWL , HerrmannSD , MeckesN , BassettDRJr , Tudor‐LockeC , et al. The compendium of physical activities tracking guide. Healthy Lifestyles Research Center, College of Nursing &amp; Health Innovation, Arizona State University. sites.google.com/site/compendiumofphysicalactivities/home (accessed 7 May 2012). ">Ainsworth 2012</a>). </p> </section> <section id="CD012044-sec-0047"> <h3 class="title" id="CD012044-sec-0047">How the intervention might work</h3> <p>Physical activity is known to confer general health benefits (<a href="./references#CD012044-bbs2-0068" title="WarburtonDER , NicolCR , BredinSSD . Health benefits of physical activity: the evidence. Canadian Medical Association Journal2006;174(6):801‐9. [DOI: 10.1503/cmaj.051351] ">Warburton 2006</a>) and holds promise as a potential first‐line or complementary intervention for treating LUTS/BPO (<a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0058" title="RussoGI , CastelliT , UrzìD , PriviteraS , LaVigneraS , CondorelliRA , et al. Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematic review. International Journal of Urology2015;22(11):982‐90. [DOI: 10.1111/iju.12877] ">Russo 2015</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>). Physical activity interventions for LUTS/BPO may work through multiple pathways in different physiologic dimensions (<a href="./references#CD012044-bbs2-0023" title="BarkinJ . Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Canadian Journal of Urology2011;18(1):14‐9. [PUBMED: 21501546] ">Barkin 2011</a>; <a href="./references#CD012044-bbs2-0024" title="BarnardRJ , KobayashiN , AronsonWJ . Effect of diet and exercise intervention on the growth of prostate epithelial cells. Prostate Cancer and Prostatic Diseases2008;11(4):362‐6. [DOI: 10.1038/pcan.2008.6] ">Barnard 2008</a>; <a href="./references#CD012044-bbs2-0028" title="ChangRY , KooM , YuZR , KanCB , ChuIT , HsuCT , et al. The effect of tai chi exercise on autonomic nervous function of patients with coronary artery disease. Journal of Alternative and Complementary Medicine2008;14(9):1107‐13. [DOI: 10.1089/acm.2008.0166] ">Chang 2008</a>; <a href="./references#CD012044-bbs2-0030" title="DeNunzioC , AhyaiS , AutorinoR , BachmannA , BialekW , BrigantiA , et al. Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. European Urology2011;60(6):1205‐6. [DOI: 10.1016/j.eururo.2011.08.055] ">De Nunzio 2011</a>; <a href="./references#CD012044-bbs2-0031" title="DonnellRF . Benign prostate hyperplasia: a review of the year’s progress from bench to clinic. Current Opinion in Urology2011;21(1):22‐6. [DOI: 10.1097/MOU.0b013e32834100dd] ">Donnell 2011</a>; <a href="./references#CD012044-bbs2-0032" title="DumoulinC , Hay‐SmithJ , FrawleyH , McClurgD , AlewijnseD , BoK , et al. 2014 consensus statement on improving pelvic floor muscle training adherence: International Continence Society 2011 State‐of‐the‐Science Seminar. Neurourology and Urodynamics2015;34(7):600‐5. [DOI: 10.1002/nau.22796] ">Dumoulin 2015</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>; <a href="./references#CD012044-bbs2-0061" title="SilvaTL , MotaMM , FontesMT , AraújoJE , CarvalhoVO , BonjardimLR , et al. Effects of one resistance exercise session on vascular smooth muscle of hypertensive rats. Arquivos Brasileiros de Cardiologia2015;105(2):160‐7. [DOI: 10.5935/abc.20150070] ">Silva 2015</a>): strengthening the pelvic floor; promoting activity of the parasympathetic nervous system and reducing excitement of the sympathetic nervous system (an effect similar to that of alpha‐blocker drugs); decreasing resting sympathetic tone in the prostate; improving hormonal milieu through modulation of insulin and testosterone; reducing prostate inflammation through decreased oxidative damage; reducing the contractile response of smooth muscle; and reducing growth of prostate primary epithelial cells. In addition, immunologic function and antioxidant defence shows improvement with exercise, further protecting against comorbidities (<a href="./references#CD012044-bbs2-0068" title="WarburtonDER , NicolCR , BredinSSD . Health benefits of physical activity: the evidence. Canadian Medical Association Journal2006;174(6):801‐9. [DOI: 10.1503/cmaj.051351] ">Warburton 2006</a>). </p> <p>Physical activity might also have a clinically important placebo effect. Based on a network meta‐analysis of monodrug therapy for LUTS/BPO (<a href="./references#CD012044-bbs2-0071" title="YuanJQ , MaoC , WongSY , YangZY , FuXH , DaiXY , et al. Comparative effectiveness and safety of monodrug therapies for lower urinary tract symptoms associated with benign prostatic hyperplasia: a network meta‐analysis. Medicine2015;94(27):e974. [DOI: 10.1097/MD.0000000000000974] ">Yuan 2015</a>), the placebo effect on the IPSS was around 20%: mean changes from baseline (17.85) of ‐3.39 (95% confidence interval ‐6.68 to ‐0.10; 89 trials, 48,854 men). </p> </section> <section id="CD012044-sec-0048"> <h3 class="title" id="CD012044-sec-0048">Why it is important to do this review</h3> <p>Because the prevalence of LUTS/BPO increases with age, the burden and number of men complaining of LUTS will rise as life expectancy increases and the elderly population grows. Consequently, there will be an increased demand for treatment services and a need to incorporate evidence‐based medicine in treatments. Several Cochrane Reviews for LUTS/BPO focusing on drugs and supplements, health technology assessments, and surgery have been published in the Cochrane Library (<a href="./references#CD012044-bbs2-0036" title="GarimellaPS , FinkHA , MacDonaldR , WiltTJ . Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD007360.pub2] ">Garimella 2009</a>; <a href="./references#CD012044-bbs2-0046" title="HoffmanRM , MacDonaldR , WiltT . Laser prostatectomy for benign prostatic obstruction. Cochrane Database of Systematic Reviews2000, Issue 1. [DOI: 10.1002/14651858.CD001987.pub2] ">Hoffman 2000</a>; <a href="./references#CD012044-bbs2-0047" title="HoffmanRM , MongaM , ElliottSP , MacDonaldR , LangsjoenJ , TacklindJ , et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD004135.pub3] ">Hoffman 2012</a>; <a href="./references#CD012044-bbs2-0063" title="TacklindJ , FinkHA , MacDonaldR , RutksI , WiltTJ . Finasteride for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD006015.pub3] ">Tacklind 2010</a>; <a href="./references#CD012044-bbs2-0064" title="TacklindJ , MacDonaldR , RutksI , StankeJU , WiltTJ . Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD001423.pub3] ">Tacklind 2012</a>; <a href="./references#CD012044-bbs2-0069" title="WiltTJ , IshaniA . Pygeum africanum for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews1998, Issue 1. [DOI: 10.1002/14651858.CD001044] ">Wilt 1998</a>; <a href="./references#CD012044-bbs2-0070" title="WiltTJ , IshaniA , MacDonaldR , StarkG , MulrowCD , LauJ . Beta‐sitosterols for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews1999, Issue 3. [DOI: 10.1002/14651858.CD001043] ">Wilt 1999</a>). Physical activity could prove to be a first‐line and complementary intervention for treating LUTS/BPO (<a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0058" title="RussoGI , CastelliT , UrzìD , PriviteraS , LaVigneraS , CondorelliRA , et al. Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematic review. International Journal of Urology2015;22(11):982‐90. [DOI: 10.1111/iju.12877] ">Russo 2015</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>). The American Urological Association (AUA) considers lifestyle interventions, including physical activity, as a high‐priority area for future research in LUTS/BPO (<a href="./references#CD012044-bbs2-0052" title="McVaryKT , RoehrbornCG , AvinsAL , BarryMJ , BruskewitzRC , DonnellRF , et al. Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology2011;185(5):1793‐803. [DOI: 10.1016/j.juro.2011.01.074] ">McVary 2011</a>). Evidence at different levels, including clinical trials (e.g. <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>) and reviews of nonrandomised trials not conducted by Cochrane, has shown that physical activity may improve LUTS/BPO (<a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>). However, no Cochrane Review to date has assessed the evidence for physical activity as a potential intervention for LUTS/BPO. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012044-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-sec-0049">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-sec-0189">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012044-sec-0049"></div> <p>To assess the effects of physical activity on lower urinary tract symptoms due to benign prostatic obstruction. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012044-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-sec-0050">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-sec-0190">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012044-sec-0050"></div> <section id="CD012044-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012044-sec-0052"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and controlled clinical trials (CCTs), both published and unpublished, without restriction on language, date, or publication status. </p> </section> <section id="CD012044-sec-0053"> <h4 class="title">Types of participants</h4> <p>We included only men diagnosed with LUTS by symptom scores (e.g. IPSS, DAN‐PSS) presumably due to BPO. We excluded studies that included men with a history suggestive of non‐BPO causes of LUTS (<a href="./references#CD012044-bbs2-0029" title="D'SilvaKA , DahmP , WongCL . Does this man with lower urinary tract symptoms have bladder outlet obstruction? The Rational Clinical Examination: a systematic review. JAMA2014;312(5):535‐42. [DOI: 10.1001/jama.2014.5555] ">D'Silva 2014</a>; <a href="./references#CD012044-bbs2-0039" title="GratzkeC , BachmannA , DescazeaudA , DrakeMJ , MadersbacherS , MamoulakisC , et al. EAU guidelines on the assessment of non‐neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Urology2015;67(6):1099‐109. [DOI: 10.1016/j.eururo.2014.12.038] ">Gratzke 2015</a>). We used information from the study description regarding medical, neurologic, and urologic history to determine if the causes of LUTS were other than BPO, contacting study authors for additional details when necessary. </p> <p>We excluded studies that included men who had previously received invasive therapies for LUTS/BPO, since the subsequent cause of LUTS could have been other than BPO. </p> <p>We found studies involving a subset of relevant participants and contacted the study authors to request individual data but received no reply. </p> </section> <section id="CD012044-sec-0054"> <h4 class="title">Types of interventions</h4> <section id="CD012044-sec-0055"> <h5 class="title">Experimental interventions</h5> <p>We included any type of physical activity with or without concomitant interventions. We included interventions for which there were multiple interacting components. </p> <p>We excluded studies that used electrical stimulation, since this type of intervention does not fulfil the conceptual definition of physical activity, and a previously published Cochrane Review (<a href="./references#CD012044-bbs2-0025" title="BerghmansB , HendriksE , BernardsA , deBieR , OmarMI . Electrical stimulation with non‐implanted electrodes for urinary incontinence in men. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD001202.pub5] ">Berghmans 2013</a>) covers a related topic. We excluded studies in which physical activity was applied after invasive therapies for LUTS/BPO, since the subsequent cause of LUTS could be other than BPO. </p> </section> <section id="CD012044-sec-0056"> <h5 class="title">Comparator interventions</h5> <p> <ul id="CD012044-list-0003"> <li> <p>Usual treatment (e.g. alpha‐blockers, 5‐ARIs, combination therapy, invasive therapies).</p> </li> <li> <p>Watchful waiting (e.g. active surveillance, nocturnal fluid restriction, caffeine and alcohol restriction, avoidance of over‐the‐counter decongestants). </p> </li> <li> <p>Complementary and alternative medicines (e.g. <i>Serenoa repens</i> , <i>Pygeum africanum</i>). </p> </li> <li> <p>Sham physical activity for which the probability of treatment effect may be attributed to a placebo effect (e.g. stretching). </p> </li> </ul> </p> </section> </section> <section id="CD012044-sec-0057"> <h4 class="title">Types of outcome measures</h4> <p>The outcomes listed were not used as criteria for including studies in the review:</p> <section id="CD012044-sec-0058"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012044-list-0004"> <li> <p>Symptom score for LUTS using a validated instrument (e.g. IPSS, BPH Impact Index (BII)).</p> </li> <li> <p>Response rate, defined as 20% improvement in symptom score (measured by authors’ report or imputation). </p> </li> <li> <p>Withdrawal due to adverse events.</p> </li> </ul> </p> </section> <section id="CD012044-sec-0059"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012044-list-0005"> <li> <p>Change of medication use.</p> </li> <li> <p>Need for an invasive procedure (e.g. open prostatectomy, laser therapies, transurethral needle ablation, transurethral resection of the prostate, transurethral microwave therapy). </p> </li> <li> <p>Postvoid residual urine (PVR), measured by bladder scanner, transabdominal ultrasonography, or catheterisation. </p> </li> </ul> </p> <section id="CD012044-sec-0060"> <h6 class="title">Timing of outcome measurement</h6> <p>We used the outcome measure with the longest follow‐up available for the included studies. We classified the outcome measurement as ‘short term’ (taken within three months or less); ‘medium term’ (more than three months to less than 12 months); and ‘long term’ (12 months or more). We used the data at the longest follow‐up available as reported in the individual studies for the meta‐analyses. </p> </section> <section id="CD012044-sec-0061"> <h6 class="title">Main outcomes for ‘Summary of findings’ tables</h6> <p>We presented a ‘Summary of findings’ table reporting the following outcomes listed according to priority: </p> <p> <ul id="CD012044-list-0006"> <li> <p>Symptom score for LUTS;</p> </li> <li> <p>Response rate;</p> </li> <li> <p>Withdrawal due to adverse events.</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD012044-sec-0062"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012044-sec-0063"> <h4 class="title">Electronic searches</h4> <p>We developed an electronic search strategy from inception of database to 6 November 2018 and identified all potential studies from: </p> <p> <ul id="CD012044-list-0007"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (via the Cochrane Library) (<a href="./appendices#CD012044-sec-0166">Appendix 1</a>); </p> </li> <li> <p>MEDLINE (via PubMed) (<a href="./appendices#CD012044-sec-0167">Appendix 2</a>); </p> </li> <li> <p>Embase (via Ovid) <a href="./appendices#CD012044-sec-0168">Appendix 3</a>); </p> </li> <li> <p>Web of Science (via ISI Web of Knowledge, Core Collection: SCI‐EXPANDED, SSCI, A&amp;HCI, CPCI‐S, CPCI‐SSH, ESCI) (<a href="./appendices#CD012044-sec-0169">Appendix 4</a>); </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Sciences database) (via BIREME) (<a href="./appendices#CD012044-sec-0170">Appendix 5</a>). </p> </li> </ul> </p> <p>We used the sensitivity‐maximising version of the Cochrane Highly Sensitive Search Strategy to identify randomised trials in MEDLINE (<a href="./references#CD012044-bbs2-0051" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). We adapted the complete search strategy for MEDLINE provided in <a href="./appendices#CD012044-sec-0167">Appendix 2</a> for all databases under consideration. </p> <p>We searched the following trial registers independently (from inception of database to 6 November 2018): </p> <p> <ul id="CD012044-list-0008"> <li> <p>ClinicalTrials.gov (US National Institutes of Health; <a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>) (<a href="./appendices#CD012044-sec-0171">Appendix 6</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/trialsearch</a>) (<a href="./appendices#CD012044-sec-0172">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD012044-sec-0064"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all included RCTs and review articles for additional references. </p> <p>We contacted authors of the included RCTs to inquire about other published and unpublished RCTs. </p> <p>We handsearched potentially relevant RCTs published as abstracts in the following conference proceedings (conference proceedings were considered from 2013 to 6 November 2018): </p> <p> <ul id="CD012044-list-0009"> <li> <p>American Urological Association Annual Meeting (AUA; <a href="http://www.jurology.com" target="_blank">www.jurology.com</a>); </p> </li> <li> <p>Annual European Association of Urology (EAU; <a href="http://www.uroweb.org/" target="_blank">www.uroweb.org</a>); </p> </li> <li> <p>Annual Meeting of the American College of Sports Medicine (ACSM; <a href="http://www.acsm.org" target="_blank">www.acsm.org</a>). </p> </li> </ul> </p> </section> </section> <section id="CD012044-sec-0065"> <h3 class="title" id="CD012044-sec-0065">Data collection and analysis</h3> <p>We performed data collection and analysis as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012044-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). </p> <section id="CD012044-sec-0066"> <h4 class="title">Selection of studies</h4> <p>Two review authors (VS, AJG) independently assessed whether studies identified by the search met the inclusion criteria of the review. Any disagreements were resolved by discussion or by consulting a third review author (MSP) if necessary. </p> </section> <section id="CD012044-sec-0067"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (VS, AJG) independently extracted the data using a previously tested, standardised extraction form. We translated studies reported in non‐English–language journals before quality assessment. The data extraction form included PICO characteristics (participants, intervention, control, and outcome) and results from all included studies. We requested further information from study authors when necessary. We adapted the <a href="http://www.cochrane.org/sites/default/files/uploads/forums/u389/ERC%20data%20collection%20form%20for%20intervention%20reviews%20for%20RCTs%20only.doc" target="_blank">Cochrane Data Extraction and Assessment Form</a> template to meet <a href="http://www.editorial-unit.cochrane.org/mecir" target="_blank">MECIR standards</a> and the needs of this systematic review. This form contained information about the characteristics of each included study: study design, dates study was conducted, sample size, intervention and control groups, populationdemographics, inclusion and exclusion criteria, outcomes measured, methods and times of measurement, funding sources, and declarations of interest. </p> <p>We extracted outcomes data relevant to this Cochrane Review as needed for calculation of summary statistics and measures of variance. For dichotomous outcomes, we attempted to obtain numbers of events and totals for population of a 2 × 2 table, as well as summary statistics with corresponding measures of variance. For continuous outcomes, we attempted to obtain means and standard deviations or data necessary to calculate this information. </p> <p>One review author (VS) entered all data into Review Manager 5 (<a href="./references#CD012044-bbs2-0056" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and a second review author (AJG) double‐checked the entries. Any disagreements were resolved by discussion or by consulting a third review author (MSP) if necessary. </p> <p>We provided information, including trial identifiers, regarding potentially relevant ongoing studies in the Characteristics of ongoing studies table. </p> <section id="CD012044-sec-0068"> <h5 class="title">Dealing with duplicate and companion publications</h5> <p>When we found duplicate publications, companion documents, or multiple reports of a primary study, we maximised the yield of information by mapping all publications to unique studies and collating all available data. We used the most complete data set aggregated across all known publications. In case of doubt, we gave priority to the publication reporting the longest follow‐up associated with our primary or secondary outcomes. </p> </section> </section> <section id="CD012044-sec-0069"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (VS, AJG) independently used the ‘Risk of bias’ tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to assess the risk of bias for all included studies (<a href="./references#CD012044-bbs2-0044" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). A third review author (MSP) resolved any disagreements. We assessed risk of bias according to the following domains: </p> <p> <ul id="CD012044-list-0010"> <li> <p>Random sequence generation (selection bias);</p> </li> <li> <p>Allocation concealment (selection bias);</p> </li> <li> <p>Blinding of participants and personnel (performance bias);</p> </li> <li> <p>Blinding of outcome assessment (detection bias);</p> </li> <li> <p>Incomplete outcome data (attrition bias);</p> </li> <li> <p>Selective reporting (reporting bias);</p> </li> <li> <p>Other bias (other sources of bias related to a particular trial design (e.g. crossover or cluster‐randomised) or specific circumstances, e.g. interventions mixed). </p> </li> </ul> </p> <p>We classified risk of bias as low, high, or unclear in accordance with the Cochrane tool for assessment of risk of bias (<a href="./references#CD012044-bbs2-0044" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). </p> <p>For performance bias (blinding of participants and personnel) and detection bias (blinding of outcome assessment), we evaluated the risk of bias separately for each outcome according to the way of measuring (subjectively or objectively). </p> <p>We also assessed attrition bias (incomplete outcome data) on an outcome‐specific basis and grouped outcomes with similar judgements when reporting our findings in the ‘Risk of bias’ tables. </p> <p>We further summarised the risk of bias across domains for each outcome in each included study, as well as across studies and domains for each outcome. </p> <p>We defined the following endpoints as subjective outcomes:</p> <p> <ul id="CD012044-list-0011"> <li> <p>Symptom score for LUTS;</p> </li> <li> <p>Response rate.</p> </li> </ul> </p> <p>We defined the following endpoints as objective outcomes:</p> <p> <ul id="CD012044-list-0012"> <li> <p>Withdrawals due to adverse events;</p> </li> <li> <p>Change of medication use;</p> </li> <li> <p>Invasive procedure;</p> </li> <li> <p>PVR.</p> </li> </ul> </p> </section> <section id="CD012044-sec-0070"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, we summarised the results as risk ratios (RRs). In addition, we converted a statistical parameter for effect size to the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH). For continuous outcomes, we used the mean difference (MD) for measures in the same unit or the standardised mean difference (SMD) for different scales used to evaluate the same outcome. All statistical parameters used 95% confidence intervals (CIs). </p> </section> <section id="CD012044-sec-0071"> <h4 class="title">Unit of analysis issues</h4> <p>We considered the individual participant as the unit of analysis. In crossover RCTs, we used only the first period before the treatments were crossed over. When we identified trials with more than two intervention groups, we handled these in accordance with the guidance provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012044-bbs2-0045" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011c</a>). </p> </section> <section id="CD012044-sec-0072"> <h4 class="title">Dealing with missing data</h4> <p>For studies with missing data, we employed the strategies for dealing with missing data in accordance with those provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012044-bbs2-0044" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>): </p> <p> <ul id="CD012044-list-0013"> <li> <p>We tried at first to contact the study authors by sending two emails to request additional information (e.g. incomplete reporting, lack of intention‐to‐treat analysis, summary data missing for an outcome, randomisation process not described, or any other necessary data). If we did not receive an answer, we reported and discussed this in the text, and highlighted it in tables. </p> </li> <li> <p>We described any methods used to deal with missing data.</p> </li> <li> <p>We performed sensitivity analyses to test the robustness of these assumptions.</p> </li> <li> <p>We discussed the impact of missing data on the results of the review.</p> </li> </ul> </p> <p>If data were available, we performed intention‐to‐treat analyses; otherwise, we performed available‐case analyses. </p> <p>We used imputation of data to estimate the response rate (<a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>). </p> <p>Where means and standard deviations (SDs) were not reported and we were unable to obtain the necessary information from the study authors, we imputed these values by estimating from the median, range, and the size of the sample, in accordance with the methods reported by <a href="./references#CD012044-bbs2-0049" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13] ">Hozo 2005</a>. </p> </section> <section id="CD012044-sec-0073"> <h4 class="title">Assessment of heterogeneity</h4> <p>If we performed meta‐analyses, we planned to assess heterogeneity by visual inspection of the forest plot and considering the Chi<sup>2</sup> test (with a significance level of P &lt; 0.10). We planned to use the I<sup>2</sup> statistic when performing a fixed‐effect meta‐analysis, considering an I<sup>2</sup> greater than 50% as indicative of substantial heterogeneity; we planned to use Tau<sup>2</sup> when performing a random‐effects meta‐analysis, considering a Tau<sup>2</sup> greater than 1 as indicative of substantial heterogeneity. </p> </section> <section id="CD012044-sec-0074"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain study protocols for the included studies to assess for selective outcome reporting. </p> <p>As only six studies were included in the review, we did not assess the likelihood of publication bias using a funnel plot. </p> </section> <section id="CD012044-sec-0075"> <h4 class="title">Data synthesis</h4> <p>We did not find good evidence for homogeneous effects across studies; thus we summarised data using a random‐effects model. We interpreted random‐effects meta‐analyses with due consideration of the whole distribution of effects. In addition, we performed statistical analyses according to the statistical guidelines contained in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012044-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We performed meta‐analysis using an inverse‐variance method for dichotomous and continuous outcomes. When data were sparse for dichotomous outcomes (e.g. low event rates or small study size), we used the Mantel‐Haenszel method. We used Review Manager 5 software to perform analyses (<a href="./references#CD012044-bbs2-0056" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). When meta‐analysis was not possible, we provided a narrative synthesis of the available evidence. </p> <section id="CD012044-sec-0076"> <h5 class="title">‘Summary of findings’ table</h5> <p>We presented the overall quality of the evidence for each outcome according to the GRADE approach, which takes into account five criteria related not only to internal validity (risk of bias, inconsistency, imprecision, publication bias), but also to external validity, such as directness of results (<a href="./references#CD012044-bbs2-0041" title='GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , SchünemannHJ , et al. GRADE: what is "quality of evidence" and why is it important to clinicians?. BMJ (Clinical Research Ed.)2008;336(7651):995‐8. [DOI: 10.1136/bmj.39490.551019.BE] '>Guyatt 2008</a>)<i>.</i> For each comparison, two review authors (VS, AJG) independently rated the quality of evidence for each outcome as ‘high’, ‘moderate’, ‘low’, or ‘very low’ using GRADEpro GDT (<a href="./references#CD012044-bbs2-0038" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 2 June 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a>). Any discrepancies were resolved by consensus or by consulting a third review author when necessary. For each comparison, we presented a summary of the evidence for the main outcomes in a ‘Summary of findings’ table, which provided key information about the best estimate of the magnitude of the effect in relative terms and absolute differences for each relevant comparison of alternative management strategies; numbers of participants and studies addressing each important outcome; and the rating of the overall confidence in effect estimates for each outcome (<a href="./references#CD012044-bbs2-0042" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [DOI: 10.1016/j.jclinepi.2010.04.026] ">Guyatt 2011</a>; <a href="./references#CD012044-bbs2-0059" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 11: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). When meta‐analysis was not possible, we presented the results in a narrative ‘Summary of findings’ table. </p> </section> </section> <section id="CD012044-sec-0077"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to investigate heterogeneity by performing subgroup analyses according to </p> <p> <ul id="CD012044-list-0014"> <li> <p>intensity of physical activity (e.g. light intensity (1.6 to 2.9 METs), moderate intensity (3 to 5.9 METs), and vigorous intensity (6 METs or greater)). To support intensity assessment, we used the authors’ report and the ‘Compendium of physical activities’ (<a href="./references#CD012044-bbs2-0022" title="AinsworthBE , HaskellWL , HerrmannSD , MeckesN , BassettDRJr , Tudor‐LockeC , et al. The compendium of physical activities tracking guide. Healthy Lifestyles Research Center, College of Nursing &amp; Health Innovation, Arizona State University. sites.google.com/site/compendiumofphysicalactivities/home (accessed 7 May 2012). ">Ainsworth 2012</a>); </p> </li> <li> <p>timing of outcome measurement (i.e. short term (within three months or less), medium term (more than three months to less than 12 months), and long term (12 months or more)); </p> </li> <li> <p>severity of LUTS (e.g. mild (score of 0 to 7), moderate (score of 8 to 19), or severe (score of 20 to 35)). </p> </li> </ul> </p> <p>We assessed statistical differences in subgroup analyses by CI overlap and by performing the test for subgroup differences available in Review Manager 5 (<a href="./references#CD012044-bbs2-0056" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD012044-sec-0078"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses in order to explore the influence of the following factors (when applicable) on effect sizes: </p> <p> <ul id="CD012044-list-0015"> <li> <p>restricting the analysis by taking into account risk of bias, by excluding studies at ‘high risk’ and ‘unclear risk’; </p> </li> <li> <p>using the alternative model (fixed‐effect or random‐effects) for analysis, to check the robustness of results. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012044-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012044-sec-0079"></div> <section id="CD012044-sec-0080"> <h3 class="title">Description of studies</h3> <section id="CD012044-sec-0081"> <h4 class="title">Results of the search</h4> <p>Through database searching of the Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Library, MEDLINE (via PubMed), and Embase (Ovid), Web of Science (via ISI Web of Knowledge), LILACS (Latin American and Caribbean Health Sciences) via BIREME, we identified 734 records (see <a href="#CD012044-fig-0001">Figure 1</a>). We identified an additional 13 records through other sources, including five records through handsearching reference lists, four records from the grey literature, three studies from trial register searches, and one through author contact. We screened the titles and abstracts of 747 records, excluding 713 records. We screened 34 full‐text articles, and excluded 22 references from 13 studies for the following reasons: six studies (eight references) were not RCTs or CCTs; four studies (eight references) did not investigate the target population; two studies (four references) analysed other interventions; and one study (two references) was awaiting classification. We included a total of six studies (12 references) in the review. All included studies were published in English. </p> <div class="figure" id="CD012044-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012044-sec-0082"> <h4 class="title">Included studies</h4> <p>Details of the included studies are presented in the <a href="./references#CD012044-sec-0181" title="">Characteristics of included studies</a> tables. We included six trials that randomised 652 male participants, published between 2007 and 2016 in the English language (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> was available as a brief report (the most complete version) and, although the authors shared the thesis with us, it was based in pilot and only half of the sample was available. <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> was available only as an abstract. </p> <p>We contacted the authors for further information on study methodology and results with little success. We sent study authors two emails requesting additional information but only received a response from the authors of <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>, who confirmed the diagnosis of study participants. </p> <section id="CD012044-sec-0083"> <h5 class="title">Design</h5> <p>All six included studies were parallel RCTs (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> </section> <section id="CD012044-sec-0084"> <h5 class="title">Sample sizes</h5> <p>The sample size of the included studies ranged from 41 participants, in <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>, to 222 participants, in <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>, for a total of 652 randomised men. </p> </section> <section id="CD012044-sec-0085"> <h5 class="title">Setting</h5> <p>Five included trials were single‐site studies (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>), and one was a two‐site study (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). Two studies were conducted in China (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>), one in the UK (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>), one in Korea (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>), one in the Netherlands (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>), and one in Taiwan (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> </section> <section id="CD012044-sec-0086"> <h5 class="title">Participants</h5> <p>Participants were over the age of 40 years; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> included the youngest participants (mean 58.0, standard deviation (SD) 6.8) and <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> the oldest (mean 70.7, SD 4.9). Race/ethnicity was described in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> (77% white and 23% non‐white (black, Asian, other)) and <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> (100% Chinese). The severity of LUTS by IPSS ranged from moderate to severe; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> included participants with lower severity (mean 14.7, SD 8.6), and <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> included participants with greater severity (mean 20.1, SD 6.5). Postvoid residual urine (mL) was reported by <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> (median 36.8) and <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> (mean 47.3, SD 65.9). Only <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> reported prostate volume (mL) (mean 54.4, SD 27.6). Prostate‐specific antigen (PSA) (ng/mL) was reported in <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> (mean 2.1, SD 0.5) and <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> (mean 4.7, SD 4.9). Comorbidities were reported in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> (70% had one or more comorbidities) and <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> (89% had one or more comorbidities), but specific comorbidities were not reported. </p> <p>The included trials failed to report several baseline characteristics: Four studies did not report on race or ethnicity (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). Five studies did not report on PVR and prostate volume (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). Four studies did not report on PSA (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). Four studies did not report on comorbidities (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> </section> <section id="CD012044-sec-0087"> <h5 class="title">Interventions</h5> <p>Physical activity was used as experimental intervention and included tai chi, pelvic floor exercise, and intense exercise. The physical activity intervention used in four studies was pelvic floor exercise (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>); of these four studies, two used pelvic floor exercise as part of self‐management programme (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>); one used only pelvic floor exercise (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>); and the fourth study applied the intervention concomitant to tamsulosin (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). One study used tai chi as the physical activity intervention (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>). The newest study used some type of unreported intense exercise as part of a weight‐reduction programme (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>The intensity of physical activity was light in four studies (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>); moderate in one study (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); and in one study physical activity might be considered vigorous (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> only reported "intense exercise"). <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> described the frequency and volume of physical activity as "daily" (without further detail), 30 min/day. <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> applied tai chi 3 times/week, 60 min/day. Four studies did not report the frequency and volume of physical activity (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>In <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>, <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>, and <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>, the sessions were designed to enable the participants to learn and perform the interventions individually. The remaining three studies did not report clearly how interventions were performed (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). In <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> and <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>, the self‐management programme included six components: education and reassurance, fluid management, caffeine and alcohol, concurrent medication, toilet and bladder retraining, and miscellaneous. In <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>, participants were informed about micturition behaviour; taught breathing, relaxation, and proprioceptive exercises; and instructed to perform the pelvic floor exercises at home. <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> instructed participants to perform tai chi at home, using warm‐up exercise (15 min), 20 main movements (40 min), and a cool‐down exercise (5 min). <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> used a "comprehensive weight reduction program" (weight reduction protocol, medical nutrition therapy, and integrated assessment with counseling) without providing further detail. One study did not provide details (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> <p>The main comparator intervention was watchful waiting, which was used in five studies (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> used alpha‐blockers (tamsulosin 0.4 mg or alfuzosin 10 mg daily) as the comparator. </p> <p>Five studies used concomitant interventions. Three studies provided standard information on LUTS/BPO and its corresponding therapies for all participants (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>). In two studies, all participants received an alpha‐blocker (tamsulosin) (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>Duration of treatment ranged from eight weeks to 12 months. The follow‐up was short term (within three months or less) in three studies (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>); medium term (more than three months to less than 12 months) in two studies (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>); and long term (12 months or more) in one study (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). </p> </section> <section id="CD012044-sec-0088"> <h5 class="title">Outcomes</h5> <p>A detailed description of the characteristics of included studies is presented in <a href="./references#CD012044-sec-0181" title="">Characteristics of included studies</a>. The following is a brief overview: </p> <p>All six included studies reported primary outcomes. Six studies reported ‘symptom score for LUTS’ by IPSS score (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). The included studies did not report data for the outcome ‘response rate’, and the study authors did not respond to our emails; it was possible to impute data by Furukawa’s method (<a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>), and we were able to impute this outcome based on IPSS score for four studies (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). Five studies reported the outcome ‘withdrawal due to adverse events’ (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>Three studies reported secondary outcomes. One study reported ‘change of medication use’ and ‘need for an invasive procedure’ (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). Two studies reported PVR (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). Postvoid residual urine was reported incompletely in <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>, and it was not possible extract or impute data. </p> </section> <section id="CD012044-sec-0089"> <h5 class="title">Funding and conflicts</h5> <p>Five studies specified funding sources (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>); the remaining study did not report this information (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> <p>One study declared a conflict of interest for one researcher who received fees from pharmaceutical companies, while all of the other authors reported no conflict of interest (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). Four studies declared no conflict of interest (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> did not declare any information regarding conflicts of interest. </p> </section> </section> <section id="CD012044-sec-0090"> <h4 class="title">Excluded studies</h4> <p>We assessed 34 full‐text articles for eligibility. We excluded 13 studies (22 references). Of these, six (eight references) were not RCTs or CCTs (<a href="./references#CD012044-bbs2-0007" title="AusmeesK , KorrovitsP , TimbergG , PunabM , MändarR . Decline of seminal parameters in middle‐aged males is associated with lower urinary tract symptoms, prostate enlargement and bladder outlet obstruction. International Brazilian Journal of Urology2013;39(5):727‐40. [DOI: 10.1590/S1677‐5538.IBJU.2013.05.16] ">Ausmees 2013</a>; <a href="./references#CD012044-bbs2-0008" title="BeyramijamM , AnooshehM , MohammadiE . Effect of designed self‐care educational program on anxiety, stress, and depression in patients with benign prostatic hyperplasia undergoing prostate surgery. Chronic Diseases Journal2013;1(2):55‐62. IRCT2012070610196N1 . The effect of designed self care educational program on anxiety, stress, depression and complications after TURP surgery in patients with benign prostatic hyperplasia. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT2012070610196N1 (first received 10 December 2012). ">Beyramijam 2013</a>; <a href="./references#CD012044-bbs2-0010" title="BrownCT , CoeJ , ColpmanD , NuttallMC , NewmanS , Van DerMeulenJ , et al. The effect on voiding patterns of a self‐management programme of lifestyle and behavioural interventions for men with uncomplicated lower urinary tract symptoms. Journal of Urology2004;171(4 Suppl):359. [DOI: 10.1016/S0022‐5347(18)38589‐6] ">Brown 2004b</a>; <a href="./references#CD012044-bbs2-0014" title="NCT00628615 . Non‐micturation bladder activity in relation to self‐consciousness during filling phase and sensation measurement during the filling phase. clinicaltrials.gov/show/NCT00628615 (first received 5 March 2008). ">NCT00628615</a>; <a href="./references#CD012044-bbs2-0015" title="NCT01576900 . The effect of combined Systematized Behavioural Modification Education Program (SyBeMeP) with DDAVP in patients with nocturia. clinicaltrials.gov/show/NCT01576900 (first received 13 April 2014). ">NCT01576900</a>; <a href="./references#CD012044-bbs2-0017" title="TibaekS , KlarskovP , Lund HansenB , ThomsenH , AndresenH , Schmidt JensenC , et al. Pelvic floor muscle training before transurethral resection of the prostate: a randomized, controlled, blinded study. Scandinavian Journal of Urology and Nephrology2007;41(4):329‐34. [DOI: 10.1080/00365590601183584] ">Tibaek 2007</a>); four studies (eight references) did not met our inclusion criteria of LUTS due to BPO (<a href="./references#CD012044-bbs2-0009" title="BreyerBN , PhelanS , HoganPE , RosenRC , KitabchiAE , WingRR , et al. Look AHEAD Research Group. Intensive lifestyle intervention reduces urinary incontinence in overweight/obese men with type 2 diabetes: results from the Look AHEAD trial. Journal of Urology2014;192(1):144‐9. [DOI: 10.1016/j.juro.2014.02.036] NCT00017953 . Look AHEAD: Action for Health in Diabetes (Look AHEAD). clinicaltrials.gov/show/NCT00017953 (first received 21 June 2001). ">Breyer 2014</a>; <a href="./references#CD012044-bbs2-0011" title="BurgioKL , GoodePS , JohnsonTM , HammontreeL , OuslanderJG , MarklandAD , et al. Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial. Journal of the American Geriatrics Society2011;59(12):2209‐16. [DOI: 10.1111/j.1532‐5415.2011.03724.x] BurgioKL , GoodePS , JohnsonTM , HammontreeLN , OuslanderJG , MarklandAD , et al. Behavioral vs. drug treatment for overactive bladder in men: The MOTIVE trial. Journal of Urology2010;183(4):e585. [DOI: 10.1016/j.juro.2010.02.2360] JohnsonTM , MarklandAD , GoodePS , VaughanCP , ColliJL , OuslanderJG , et al. Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α‐blocker therapy in men with nocturia. BJU International2013;112(1):100‐8. [DOI: 10.1111/j.1464‐410X.2012.11736.x] NCT01187498 . Behavioral Treatment of Overactive Bladder in Men (MOTIVE). clinicaltrials.gov/show/NCT01187498 (first received 24 August 2010). ">Burgio 2010</a>; <a href="./references#CD012044-bbs2-0012" title="JohnsonTM2nd , VaughanCP , GoodePS , BliwiseDL , MarklandAD , HuisinghC , et al. Pilot results from a randomized trial in men comparing alpha‐adrenergic antagonist versus behavior and exercise for nocturia and sleep. Clinical Therapeutics2016;38(11):2394‐406.e3. [DOI: 10.1016/j.clinthera.2016.10.001] NCT00824200 . Behavior and Exercise Versus Drug Treatment in Men With Nocturia (BEDTiMe). clinicaltrials.gov/show/NCT00824200 (first received 16 January 2009). ">Johnson 2016</a>; <a href="./references#CD012044-bbs2-0013" title="NCT00404638 . Treatment of enuresis nocturna by circular muscle exercise (Paula Method). clinicaltrials.gov/show/NCT00982098 (first received 22 September 2009). ">NCT00404638</a>); and two studies (four references) used physical activity in both study arms (<a href="./references#CD012044-bbs2-0016" title="NCT01294592 . Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment Naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT). clinicaltrials.gov/show/NCT01294592 (first received 16 June 2014). RoehrbornCG , Oyarzabal PerezI , RoosEP , CalomfirescuN , BrothertonB , PalaciosJM , et al. Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2‐year CONDUCT study. World Journal of Urology2017;35(3):421‐7. [DOI: 10.1007/s00345‐016‐1884‐5] RoehrbornCG , Oyarzabal PerezI , RoosEP , CalomfirescuN , BrothertonB , WangF , et al. Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year CONDUCT study results. BJU International2015;116(3):450‐9. [DOI: 10.1111/bju.13033] ">Roehrborn 2015</a>). For further details, see <a href="./references#CD012044-sec-0182" title="">Characteristics of excluded studies</a>. <a href="./references#CD012044-bbs2-0019" title="ChiCTR‐IOR‐16007698 . Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia‐related outcomes in older adults: study protocol for a randomized controlled trial. www.chictr.org.cn/showprojen.aspx?proj=12814 (first received 4 January 2016). LiuX , HuangG , ChenP , LiY , XiangJ , ChenT , et al. Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia‐related outcomes in older adults: study protocol for a randomized controlled trial. Trials2016;17(1):319. [DOI: 10.1186/s13063‐016‐1448‐4] ">Liu 2016</a> is awaiting classification (see below). </p> <section id="CD012044-sec-0091"> <h5 class="title">Studies awaiting classification</h5> <p>We identified one completed study (two references) in accordance to study dates (<a href="./references#CD012044-bbs2-0019" title="ChiCTR‐IOR‐16007698 . Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia‐related outcomes in older adults: study protocol for a randomized controlled trial. www.chictr.org.cn/showprojen.aspx?proj=12814 (first received 4 January 2016). LiuX , HuangG , ChenP , LiY , XiangJ , ChenT , et al. Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia‐related outcomes in older adults: study protocol for a randomized controlled trial. Trials2016;17(1):319. [DOI: 10.1186/s13063‐016‐1448‐4] ">Liu 2016</a>), but the article or results were not posted. A multiple‐arm trial was planned to assess the effects of yi jin jing versus tai chi versus watchful waiting. The study protocol is summarised in <a href="./references#CD012044-sec-0183" title="">Characteristics of studies awaiting classification</a>. We contacted the authors but received no response. We will consider this study in future updates of this review. </p> </section> <section id="CD012044-sec-0092"> <h5 class="title">Ongoing studies</h5> <p>We did not identify any ongoing studies.</p> </section> </section> </section> <section id="CD012044-sec-0093"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the risk of bias of the included studies according to the seven domains outlined in the Cochrane ‘Risk of bias’ tool (<a href="./references#CD012044-bbs2-0044" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). Two studies (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>) had available protocols and published reports to extracted the methodological details; the remaining studies (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>) data extraction was based only on the published reports. For an overview of review authors’ judgements about each ‘Risk of bias’ item for individual studies and across all studies, see <a href="#CD012044-fig-0002">Figure 2</a> and <a href="#CD012044-fig-0003">Figure 3</a>. For details on the risk of bias of the included studies, see <a href="./references#CD012044-sec-0181" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD012044-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012044-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors’ judgements about each risk of bias item for each included study." data-id="CD012044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors’ judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012044-sec-0094"> <h4 class="title">Allocation</h4> <section id="CD012044-sec-0095"> <h5 class="title">Random sequence generation</h5> <p>Three studies reported adequate methods for sequence generation and were judged as at low risk of bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>). For the other three included studies (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>), information on sequence generation was not reported or was insufficient to permit a judgement (unclear risk of bias). </p> </section> <section id="CD012044-sec-0096"> <h5 class="title">Allocation concealment</h5> <p>Four studies provided insufficient information to enable assessment (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). We classified the remaining two studies as at high risk of bias: <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> declared that they did not perform allocation concealment, and <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> changed the allocation concealment procedure, increasing the risk of selection bias. </p> </section> </section> <section id="CD012044-sec-0097"> <h4 class="title">Blinding</h4> <section id="CD012044-sec-0098"> <h5 class="title">Blinding of participants and personnel</h5> <p>The nature of the study interventions (physical activity) implies that blinding of participants and personnel was not possible. </p> <p>We considered the subjective outcomes (symptom score for LUTS and response rate) as at high risk of bias for blinding participants and personnel for all six included studies, since the study interventions meant that blinding of participants was not possible and that all outcomes were susceptible to bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>; <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>We rated objective outcomes (withdrawals due to adverse events, change of medication use, need for invasive procedure, and PVR) as at low risk of bias, since participants attended the appointments at which objectives outcomes were measured. One study did not report objective outcomes and was judged as at unclear risk of bias (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> <p>Three studies were at high risk of performance bias due to co‐interventions (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> </section> <section id="CD012044-sec-0099"> <h5 class="title">Blinding of outcome assessment</h5> <p>Only one study blinded outcome assessment for subjective outcomes (symptom score for LUTS and response rate) and was judged as at low risk of bias (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>). We judged three open‐label studies as at high risk of bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>). There was insufficient information to make a judgement for the remaining two studies (unclear risk of bias) (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>; <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>). </p> <p>We rated objective outcomes (withdrawals due to adverse events, change of medication use, need for invasive procedure, and PVR) as at low risk of bias, since participants attended the appointments at which objectives outcomes were measured. One study did not report objective outcomes and was judged as at unclear risk of bias (<a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> </section> </section> <section id="CD012044-sec-0100"> <h4 class="title">Incomplete outcome data</h4> <p>We classified three studies as at low risk of bias: <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> included all randomised participants in the final analysis; <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> applied last observation carried forward to impute missing data of 25 randomised participants in the final analysis and performed sensitivity analysis demonstrating that the loss to follow‐up did not have a clinically relevant impact; and <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> lost one participant from each group, which we judged as not having a clinically relevant impact. We assessed two studies as at high risk of bias: <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> included only half of all randomised participants (28/56) in the final analysis; and <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> included only a part of the 50 missing randomised participants with an unclear explanation, resulting in a biased attempt to impute missing data. We judged <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> as at unclear risk of bias due to insufficient information to permit a judgement about exclusions and a lack of reporting of missing data (the study was available in abstract form only). Subjective and objective outcomes showed the same judgement and were grouped here. </p> </section> <section id="CD012044-sec-0101"> <h4 class="title">Selective reporting</h4> <p>Only two studies registered their trials before conducting the study (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>). </p> <p>We judged four studies as at high risk of bias. We found differences between the protocols and the study reports in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>. <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> reported outcomes incompletely. <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> planned to include participants with an IPSS score of greater than 25, but there was evidence of protocol deviation and/or violation. Although <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> did not register the study protocol, we judged the study as at high risk of bias because not all timing of outcome measurements proposed in the methods section were reported. </p> <p>We classified the remaining two studies as at unclear risk of bias because they provided insufficient information to enable an assessment of low or high risk (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). </p> </section> <section id="CD012044-sec-0102"> <h4 class="title">Other potential sources of bias</h4> <p>We considered three studies to be at high risk of bias. In <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> there were changes in the advice that clinicians gave to the comparator group and direct communication between participants allocated to different groups. In <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>, baseline characteristics were based on half of the randomised participants, and there was a risk to compromise baseline comparability of groups. In (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>), the description of intervention was nonreproducible, since it was reported with incompleteness. </p> <p>We classified one study in which there were no differences in baseline characteristics and we did not identify sources of other bias as at low risk of bias (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>). </p> <p>In two studies there was insufficient information to permit a judgement (unclear risk of bias): <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> was available only as a thesis (with a half of the participants included in final publication) and brief report, and <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> was available only as an abstract. </p> </section> </section> <section id="CD012044-sec-0103"> <h3 class="title" id="CD012044-sec-0103">Effects of interventions</h3> <p>See: <a href="./full#CD012044-tbl-0001"><b>Summary of findings for the main comparison</b> Physical activity compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</a>; <a href="./full#CD012044-tbl-0002"><b>Summary of findings 2</b> Physical activity as part of self‐management programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</a>; <a href="./full#CD012044-tbl-0003"><b>Summary of findings 3</b> Physical activity as part of weight reduction programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</a>; <a href="./full#CD012044-tbl-0004"><b>Summary of findings 4</b> Physical activity compared to alpha‐blockers for lower urinary tract symptoms secondary to benign prostatic obstruction</a> </p> <section id="CD012044-sec-0104"> <h4 class="title">Physical activity versus watchful waiting</h4> <p>See <a href="./full#CD012044-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>We included two studies in this comparison (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>). <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> used pelvic floor exercise for two months, and <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> used tai chi for three months; both used a short‐term follow‐up for men with moderate LUTS. <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> was only available as a conference abstract and did not report results in a form that could be extracted for meta‐analysis. </p> <section id="CD012044-sec-0105"> <h5 class="title">Primary outcomes</h5> <section id="CD012044-sec-0106"> <h6 class="title">Symptom score for LUTS</h6> <p>One study reported data for this outcome (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>). We are uncertain whether physical activity improves symptom score for LUTS by IPSS compared to watchful waiting (mean difference (MD) ‐8.1, 95% confidence interval (CI) ‐13.2 to ‐3.1; 1 study; 28 participants; <a href="./references#CD012044-fig-0007" title="">Analysis 1.1</a>). We assessed the quality of evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p><a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a> measured IPSS but did not report results in a form that could be extracted for data and analyses. </p> </section> <section id="CD012044-sec-0107"> <h6 class="title">Response rate (20% improvement)</h6> <p>We are uncertain about the effect of physical activity compared to watchful waiting for response rate (risk ratio (RR) 1.80, 95% CI 0.81 to 4.02; 1 study; 28 participants; <a href="./references#CD012044-fig-0008" title="">Analysis 1.2</a>). Physical activity would result in 286 more men per 1000 (68 fewer to 1079 more) reporting a response rate. We assessed the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0001">summary of findings Table for the main comparison</a>). We attempted contact with <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a> twice without response, after which we imputed data in accordance with <a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>. </p> </section> <section id="CD012044-sec-0108"> <h6 class="title">Withdrawal due to adverse events</h6> <p>One study reported data for this outcome (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>). We are uncertain about the effect of physical activity compared to watchful waiting on withdrawal due to adverse events (RR 1.00, 95% CI 0.59 to 1.69; 1 study; 56 participants; <a href="./references#CD012044-fig-0009" title="">Analysis 1.3</a>). Physical activity would result in 0 fewer men withdrawing due to adverse events per 1000 (205 fewer to 345 more). We assessed the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0001">summary of findings Table for the main comparison</a>). There were 28 withdrawals overall in <a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>: </p> <p> <ul id="CD012044-list-0016"> <li> <p>14 in the physical activity group for the following reasons: did not attend after allocation (n = 3), fracture (n = 1), business trip (n = 1), attend to a spouse (n = 1), no desire (n = 5), and low attendance rate (n = 3); and </p> </li> <li> <p>14 in the watchful waiting group for the following reasons: lost contact (n = 10), hospitalisation (n = 2), and taking medication (n = 2). </p> </li> </ul> </p> </section> </section> <section id="CD012044-sec-0109"> <h5 class="title">Secondary outcomes</h5> <section id="CD012044-sec-0110"> <h6 class="title">Change of medication use</h6> <p>None of the studies reported data on change of medication use.</p> </section> <section id="CD012044-sec-0111"> <h6 class="title">Need for an invasive procedure</h6> <p>None of the studies reported data on need for an invasive procedure.</p> </section> <section id="CD012044-sec-0112"> <h6 class="title">Postvoid residual urine</h6> <p>None of the studies reported data on PVR.</p> </section> </section> <section id="CD012044-sec-0113"> <h5 class="title">Subgroup analyses</h5> <p>We did not perform subgroup analyses because there were not enough studies to estimate effects in various subgroups. </p> </section> <section id="CD012044-sec-0114"> <h5 class="title">Sensitivity analyses</h5> <p>We did not perform sensitivity analyses because there were not enough studies included in the analysis to explore the data. </p> </section> <section id="CD012044-sec-0115"> <h5 class="title">Assessment of reporting bias</h5> <p>We did not draw funnel plots due to the limited number of included studies.</p> </section> </section> <section id="CD012044-sec-0116"> <h4 class="title">Physical activity as part of self management programme versus watchful waiting</h4> <p>See <a href="./full#CD012044-tbl-0002">summary of findings Table 2</a>. </p> <p>We included two studies in this comparison (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>), both of which used pelvic floor exercise as one of multiple interacting components of the experimental intervention. <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> performed long‐term follow‐up, reporting outcomes at 12 months for men with moderate LUTS. <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> used a medium‐term follow‐up, reporting outcomes at six months for men with predominantly severe LUTS. </p> <section id="CD012044-sec-0117"> <h5 class="title">Primary outcomes</h5> <section id="CD012044-sec-0118"> <h6 class="title">Symptom score for LUTS</h6> <p>Two studies reported continuous data for symptom score for LUTS by IPSS (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>). We are uncertain about the effect of physical activity as part of a self‐management programme compared to watchful waiting on symptom score for LUTS (MD ‐6.2, 95% CI ‐9.9 to ‐2.5; 2 studies; 362 participants; <a href="./references#CD012044-fig-0010" title="">Analysis 2.1</a>; <a href="#CD012044-fig-0004">Figure 4</a>). We identified substantial statistical heterogeneity (I<sup>2</sup> = 87%). We judged the quality of the evidence for this outcome to be very low due to study limitations, inconsistency, indirectness, and imprecision (<a href="./full#CD012044-tbl-0002">summary of findings Table 2</a>). </p> <div class="figure" id="CD012044-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.1 Symptom score for LUTS." data-id="CD012044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.1 Symptom score for LUTS. </p> </div> </div> </div> </section> <section id="CD012044-sec-0119"> <h6 class="title">Response rate (20% improvement)</h6> <p>We are uncertain about the effect of physical activity as part of a self‐management programme compared to watchful waiting on response rate (RR 2.36, 95% CI 1.32 to 4.21; number needed to treat for an additional beneficial outcome (NNTB) = 2, 95% CI 1 to 5; 2 studies; 362 participants; <a href="./references#CD012044-fig-0011" title="">Analysis 2.2</a>; <a href="#CD012044-fig-0005">Figure 5</a>). The intervention would result in 424 more men per 1000 (100 more to 1001 more) reporting a response rate. We identified substantial statistical heterogeneity (I<sup>2</sup> = 83%). We judged the quality of the evidence for this outcome to be very low due to study limitations, inconsistency, indirectness, and imprecision (<a href="./full#CD012044-tbl-0002">summary of findings Table 2</a>). The authors of <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> and <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> did not respond to our two contacts by email. We imputed the outcome data in accordance with <a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>. </p> <div class="figure" id="CD012044-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.2 Response rate." data-id="CD012044-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.2 Response rate. </p> </div> </div> </div> </section> <section id="CD012044-sec-0120"> <h6 class="title">Withdrawal due to adverse events</h6> <p>Two studies reported data for withdrawal due to adverse events (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>). We are uncertain about the effects of physical activity as part of a self‐management programme versus watchful waiting on this outcome (risk difference (RD) 0.00, 95% CI ‐0.05 to 0.06; 2 studies; 362 participants; <a href="./references#CD012044-fig-0012" title="">Analysis 2.3</a>; <a href="#CD012044-fig-0006">Figure 6</a>). We identified moderate statistical heterogeneity (I<sup>2</sup> = 33%). Physical activity as part of a self‐management programme would result in 65 fewer men withdrawing due to adverse events per 1000 (65 fewer to 65 fewer). We judged the quality of the evidence for this outcome to be very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0002">summary of findings Table 2</a>). </p> <div class="figure" id="CD012044-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.3 Withdrawal due to adverse events." data-id="CD012044-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.3 Withdrawal due to adverse events. </p> </div> </div> </div> <p>There were 25 withdrawals (14 in the physical activity group and 11 in the watchful waiting group). We were unable to present numbers defined to reasons of withdrawals due to recounts, which cannot be separated for an inaccurate description. However, the reasons reported for the withdrawals in the study are attributed to changes in intervention and/or clinical condition (alpha‐blocker, anticholinergic, surgery, catheterised for acute urinary retention, and rise in IPSS of ≥ 3 points). </p> </section> </section> <section id="CD012044-sec-0121"> <h5 class="title">Secondary outcomes</h5> <section id="CD012044-sec-0122"> <h6 class="title">Change of medication use</h6> <p>One study reported data for change of medication use (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). Long‐term data were reported, and there might be an observed reduction in needed drug therapy favouring physical activity as part of self‐management programme compared to watchful waiting (RR 0.48, 95% CI 0.25 to 0.92; NNTB = 6, 95% CI 3 to 50; 1 study; 140 participants; <a href="./references#CD012044-fig-0013" title="">Analysis 2.4</a>). </p> </section> <section id="CD012044-sec-0123"> <h6 class="title">Need for an invasive procedure</h6> <p>One study reported data for need for an invasive procedure (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>). The study reported the data for long term. The need for an invasive procedure might not differ between the physical activity as part of self‐management programme group and the watchful waiting group (RR 0.31, 95% CI 0.03 to 2.87; 1 study; 140 participants; <a href="./references#CD012044-fig-0014" title="">Analysis 2.5</a>). </p> </section> <section id="CD012044-sec-0124"> <h6 class="title">Postvoid residual urine</h6> <p>None of the studies reported data on PVR.</p> </section> </section> <section id="CD012044-sec-0125"> <h5 class="title">Subgroup analyses</h5> <p>See <a href="./references#CD012044-fig-0010" title="">Analysis 2.1</a>, <a href="./references#CD012044-fig-0011" title="">Analysis 2.2</a>, and <a href="./references#CD012044-fig-0012" title="">Analysis 2.3</a>. </p> <p>We were able to perform subgroup analyses for timing of outcome measurement to primary outcomes. The data at the longest follow‐up available were measured in <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a> at medium term at six months and in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> at long term at 12 months. The subgroup interaction test indicated a possible difference in effect for symptom score for LUTS (Chi<sup>2</sup> = 7.96, P = 0.005, I<sup>2</sup> = 87.4%; <a href="#CD012044-fig-0004">Figure 4</a>) and response rate (Chi<sup>2</sup> = 5.78, P = 0.02, I<sup>2</sup> = 82.7%; <a href="#CD012044-fig-0005">Figure 5</a>), but not for withdrawals due to adverse events (Chi<sup>2</sup> = 0.18, P = 0.67, I<sup>2</sup> = 0%; <a href="#CD012044-fig-0006">Figure 6</a>) based on timing of outcome measurement. Two reasons might explain the heterogeneity and the smaller effect size in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>: 1) there is evidence of changes in the advice that the clinicians gave to the comparator group (watchful waiting), and (2) direct communication between men allocated to different groups. Although there were differences in the duration of the intervention (12 months in <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a> and six months in <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>), this may not be the reason for the heterogeneity, since the effect size at six months is consistent at 12 months for <a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>. </p> </section> <section id="CD012044-sec-0126"> <h5 class="title">Sensitivity analyses</h5> <p>We did not perform sensitivity analyses because there were not enough studies included in the analysis to explore the data. </p> </section> <section id="CD012044-sec-0127"> <h5 class="title">Assessment of reporting bias</h5> <p>We did not draw funnel plots due to the limited number of included studies.</p> </section> <section id="CD012044-sec-0128"> <h5 class="title">Ongoing studies</h5> <p>We did not identify any ongoing studies for this comparison.</p> </section> </section> <section id="CD012044-sec-0129"> <h4 class="title">Physical activity as part of weight reduction programme versus watchful waiting</h4> <p>See <a href="./full#CD012044-tbl-0003">summary of findings Table 3</a>. </p> <p>We included one study in this comparison. <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> used some type of (unclear) vigorous exercise as one of multiple interacting components of the experimental intervention in men with moderate LUTS at medium‐term follow‐up (48 weeks). </p> <section id="CD012044-sec-0130"> <h5 class="title">Symptom score for LUTS</h5> <p><a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> reported data for this outcome. We are uncertain about the effect of physical activity as part of a weight reduction programme for symptom score for LUTS compared to watchful waiting (MD ‐1.1, 95% CI ‐3.5 to 1.3; 1 study; 117 participants; <a href="./references#CD012044-fig-0015" title="">Analysis 3.1</a>). We rated the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD012044-sec-0131"> <h5 class="title">Response rate (20% improvement)</h5> <p>We are uncertain of the effect of physical activity as part of a weight reduction programme compared to watchful waiting on response rate (RR 1.20, 95% CI 0.74 to 1.94; 1 study; 117 participants; <a href="./references#CD012044-fig-0016" title="">Analysis 3.2</a>). The intervention would result in 67 more men per 1000 (87 fewer to 313 more) reporting a response rate. We rated the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0003">summary of findings Table 3</a>). We attempted two contacts with <a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> without receiving a response, after which we imputed data in accordance with <a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>. </p> </section> <section id="CD012044-sec-0132"> <h5 class="title">Withdrawal due to adverse events</h5> <p><a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> reported data for this outcome. We are uncertain of the effect of the intervention on withdrawal due to adverse events (RR 1.63, 95% CI 1.03 to 2.57; number needed to treat for an additional harmful outcome (NNTH) = 6, 95% CI 3 to 50; 1 study; 130 participants; <a href="./references#CD012044-fig-0017" title="">Analysis 3.3</a>). Physical activity as part of weight reduction programme would result in 184 more men withdrawing due to adverse events per 1000 (9 more to 459 more). We rated the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0003">summary of findings Table 3</a>). </p> </section> <section id="CD012044-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD012044-sec-0134"> <h6 class="title">Change of medication use</h6> <p>The study did not report data on change of medication use.</p> </section> <section id="CD012044-sec-0135"> <h6 class="title">Need for an invasive procedure</h6> <p>The study did not report data on need for an invasive procedure.</p> </section> <section id="CD012044-sec-0136"> <h6 class="title">Postvoid residual urine</h6> <p><a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a> reported data on PVR. Physical activity as part of weight reduction programme did not improve PVR compared to watchful waiting (MD ‐25.0, 95% CI ‐54.7 to 4.7; 1 study; 117 participants; <a href="./references#CD012044-fig-0018" title="">Analysis 3.4</a>). </p> </section> </section> <section id="CD012044-sec-0137"> <h5 class="title">Subgroup analyses</h5> <p>We did not perform subgroup analyses because there were not enough studies to estimate effects in various subgroups. </p> </section> <section id="CD012044-sec-0138"> <h5 class="title">Sensitivity analyses</h5> <p>We did not perform sensitivity analyses because there were not enough studies included in the analysis to explore the data. </p> </section> <section id="CD012044-sec-0139"> <h5 class="title">Assessment of reporting bias</h5> <p>We did not draw funnel plots due to the limited number of included studies.</p> </section> <section id="CD012044-sec-0140"> <h5 class="title">Ongoing studies</h5> <p>We did not identify any ongoing studies for this comparison.</p> </section> </section> <section id="CD012044-sec-0141"> <h4 class="title">Physical activity versus alpha‐blockers</h4> <p>See <a href="./full#CD012044-tbl-0004">summary of findings Table 4</a>. </p> <p>We included one study that was available as a brief report in this comparison. <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> compared pelvic floor exercise versus alpha‐blockers (tamsulosin 0.4 mg daily) applied in the short term for three months in men with moderate or severe LUTS. We attempted two contacts with the study authors without receiving a response, after which we imputed the data. </p> <section id="CD012044-sec-0142"> <h5 class="title">Primary outcomes</h5> <section id="CD012044-sec-0143"> <h6 class="title">Symptom score for LUTS</h6> <p><a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> measured symptom score for LUTS by IPSS. We are uncertain whether an improvement in the symptom score for LUTS with physical activity is comparable with alpha‐blockers (MD 2.8, 95% CI ‐0.9 to 6.4; 1 study; 39 participants; <a href="./references#CD012044-fig-0019" title="">Analysis 4.1</a>). We rated the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0004">summary of findings Table 4</a>). The authors reported median and range; we imputed mean and standard deviation according to <a href="./references#CD012044-bbs2-0049" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13] ">Hozo 2005</a>. </p> </section> <section id="CD012044-sec-0144"> <h6 class="title">Response rate (20% improvement)</h6> <p><a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> contributed to this outcome. We are uncertain whether the number of men reporting response rate for LUTS is comparable between the physical activity and alpha‐blockers groups (RR 0.80, 95% CI 0.55 to 1.15; 1 study; 39 participants; <a href="./references#CD012044-fig-0020" title="">Analysis 4.2</a>). Physical activity might result in 167 fewer men per 1000 (375 fewer to 125 more) reporting a response rate. We rated the quality of the evidence as very low due to study limitations, indirectness, and imprecision (<a href="./full#CD012044-tbl-0004">summary of findings Table 4</a>). We imputed data in accordance with <a href="./references#CD012044-bbs2-0035" title="FurukawaTA , CiprianiA , BarbuiC , BrambillaP , WatanabeN . Imputing response rates from means and standard deviations in meta‐analyses. International Clinical Psychopharmacology2005;20(1):49‐52. [PUBMED: 15602117] ">Furukawa 2005</a>. </p> </section> <section id="CD012044-sec-0145"> <h6 class="title">Withdrawal due to adverse events</h6> <p><a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> reported data for this outcome. The effects of physical activity and alpha‐blockers on withdrawal due to adverse events might be similar (RR 0.56, 95% CI 0.06 to 12.89; 1 study; 41 participants; <a href="./references#CD012044-fig-0021" title="">Analysis 4.3</a>). The intervention would result in 7 fewer men withdrawing due to adverse events per 1000 (49 fewer to 626 more). We rated the quality of the evidence as low due to indirectness and imprecision (<a href="./full#CD012044-tbl-0004">summary of findings Table 4</a>). </p> <p>The reasons for withdrawals were not available in the main publication of <a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>. We reported the reasons for withdrawals based on a subset of data from a pilot study provided by the authors through the sharing of a master’s thesis, which counted 20 men (10 in the physical activity group and 10 in the alpha‐blocker group). No withdrawals were reported for the physical activity group. Six out of 10 men in the alpha‐blocker group reported adverse effects, which included dizziness (n = 3), ejaculatory dysfunction (n = 1), itching (n = 1), and gastro‐oesophageal reflux (n = 1), but only two withdrawals occurred (1 due to dizziness and 1 due to personal circumstances). </p> </section> </section> <section id="CD012044-sec-0146"> <h5 class="title">Secondary outcomes</h5> <section id="CD012044-sec-0147"> <h6 class="title">Change of medication use</h6> <p>The study did not report data on change of medication use.</p> </section> <section id="CD012044-sec-0148"> <h6 class="title">Need for an invasive procedure</h6> <p>The study did not report data on need for an invasive procedure.</p> </section> <section id="CD012044-sec-0149"> <h6 class="title">Postvoid residual urine</h6> <p><a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a> reported data on PVR, but the data available were median and P value for Mann–Whitney test, which limits the extraction for analysis. The change score was ‐18 mL in the physical therapy group and ‐11.5 mL in the alpha‐blocker group. </p> </section> </section> <section id="CD012044-sec-0150"> <h5 class="title">Subgroup analyses</h5> <p>We did not perform subgroup analyses because there were not enough studies to estimate effects in various subgroups. </p> </section> <section id="CD012044-sec-0151"> <h5 class="title">Sensitivity analyses</h5> <p>We did not perform sensitivity analyses because there were not enough studies included in the analysis to explore the data. </p> </section> <section id="CD012044-sec-0152"> <h5 class="title">Assessment of reporting bias</h5> <p>We did not draw funnel plots due to the limited number of included studies.</p> </section> <section id="CD012044-sec-0153"> <h5 class="title">Ongoing studies</h5> <p>We did not identify any ongoing studies for this comparison.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012044-sec-0154" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012044-sec-0154">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012044-sec-0219">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012044-sec-0154"></div> <section id="CD012044-sec-0155"> <h3 class="title" id="CD012044-sec-0155">Summary of main results</h3> <p>We included six studies in this review randomising a total of 652 men in four comparisons. Men were over the age of 40 years with moderate or severe LUTS by IPSS score. These results should be interpreted with caution due to the overall very low quality of the evidence. </p> <p><b>Physical activity versus watchful waiting:</b> Two RCTs randomised 119 men. The interventions included tai chi and pelvic floor exercise. The evidence was overall very low quality, and we are uncertain about the effects of physical activity on symptom score for LUTS (MD ‐8.1, 95% CI ‐13.2 to ‐3.1), response rate (RR 1.80, 95% CI 0.81 to 4.02; 286 more men per 1000, 95% CI 68 fewer to 1000 more), and withdrawal due to adverse events (RR 1.00, 95% CI 0.59 to 1.69; 0 fewer men per 1000, 95% CI 205 fewer to 345 more). </p> <p><b>Physical activity as part of self‐management programme versus watchful waiting:</b> Two RCTs randomised 362 men. Pelvic floor exercise was one of multiple intervention components. The quality of the evidence was very low, and we are uncertain about the effects of physical activity on symptom score for LUTS (MD ‐6.2, 95% CI ‐9.9 to ‐2.5), response rate (RR 2.36, 95% CI 1.32 to 4.21; 424 more men per 1000, 95% CI 100 more to 1001 more), and withdrawal due to adverse events (RD 0.00, 95% CI ‐0.05 to 0.06; 65 fewer men per 1000, 95% CI 65 fewer to 65 fewer). </p> <p><b>Physical activity as part of weight reduction programme versus watchful waiting:</b> One RCT randomised 130 men. An unclear type of intense exercise was one of multiple intervention components. The quality of the evidence was very low, and we are uncertain about the effects of physical activity on symptom score for LUTS (MD ‐1.1, 95% CI ‐3.5 to 1.3), response rate (RR 1.20, 95% CI 0.74 to 1.94; 67 more men per 1000, 95% CI 87 fewer to 313 more), and withdrawal due to adverse events (RR 1.63, 95% CI 1.03 to 2.57; 184 more men per 1000, 95% CI 9 more to 459 more). </p> <p><b>Physical activity versus alpha‐blockers:</b> One RCT randomised 41 men to pelvic floor exercise or alpha‐blockers. The quality of the evidence was very low, and we are uncertain about the effects of physical activity on symptom score for LUTS (MD 2.8, 95% CI ‐0.9 to 6.4) and response rate (RR 0.80, 95% CI 0.55 to 1.15; 167 fewer men per 1000, 95% CI 375 fewer to 125 more). The quality of the evidence was low for withdrawal due to adverse events; the effects for this outcome may be similar between interventions (RR 0.86, 95% CI 0.06 to 12.89; 7 fewer men per 1000, 95% CI 49 fewer to 626 more). </p> </section> <section id="CD012044-sec-0156"> <h3 class="title" id="CD012044-sec-0156">Overall completeness and applicability of evidence</h3> <p>This review examined men with LUTS/BPO, one of the most common clinical complaints in men, who were treated with physical activity, an intervention well known to bring about general health benefits. Nevertheless, there were several limitations to this review that deserve consideration, as follows. </p> <p> <ul id="CD012044-list-0017"> <li> <p>Few studies have been conducted, and the existing studies have small sample sizes.</p> </li> <li> <p>In general, the studies incompletely described the baseline characteristics of the participants, such as race/ethnicity, weight, body mass index, duration of symptoms, maximal urinary flow rate (Qmax), PVR, prostate volume, PSA, and comorbidities. </p> </li> <li> <p>All six included studies reported primary outcomes, but the following points should be taken into consideration: </p> <ul id="CD012044-list-0018"> <li> <p>one trial provided only a narrative result for symptom score for LUTS;</p> </li> <li> <p>we needed to impute response rate, as no trials reported this outcome;</p> </li> <li> <p>not all studies reported withdrawal due to adverse events.</p> </li> </ul> </li> <li> <p>The trials provided incomplete information on secondary outcomes:</p> <ul id="CD012044-list-0019"> <li> <p>only one study reported the outcomes of change of medication use and need for an invasive procedure; and </p> </li> <li> <p>two studies reported data for PVR, but one study only provided information in narrative form. </p> </li> </ul> </li> <li> <p>For most of the evidence there was an insufficient outcome time frame from studies with short‐ or medium‐term follow‐up. </p> </li> <li> <p>Few types of physical activity and intensities were used. Trials often failed to report the frequency and volume of physical activity. </p> </li> <li> <p>We have no evidence of the applicability of physical activity for LUTS/BPO versus several other prespecified comparison interventions, in particular for therapies already established (e.g. 5‐ARIs, combination therapy, invasive therapies). </p> </li> </ul> </p> </section> <section id="CD012044-sec-0157"> <h3 class="title" id="CD012044-sec-0157">Quality of the evidence</h3> <p>We assessed the quality of the evidence using the GRADE approach. Overall, the quality of evidence was very low, and we are uncertain of these findings of this review. The reasons for downgrading the evidence were study limitation (i.e. allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other bias); indirectness (i.e. outcome time frame insufficient, and physical activity as one component of a complex intervention); imprecision (i.e. wide confidence interval, small sample size, and low events); and inconsistency (i.e. variation in point estimates, confidence intervals not overlapping, and heterogeneity). </p> </section> <section id="CD012044-sec-0158"> <h3 class="title" id="CD012044-sec-0158">Potential biases in the review process</h3> <p>We followed the recommendations made for study selection, data collection, and data analysis provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> in this review in order to minimise bias (<a href="./references#CD012044-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). </p> <p>The strengths of the review process were numbers of databases searched and high‐sensitivity search to detect all potentially relevant studies without language or publication status restrictions, and additionally searched trial registries for unpublished, planned, or ongoing studies. Two review authors independently assessed studies for inclusion, performed data extraction, and assessed risk of bias for all of the included studies. We previously published and followed the review protocol (<a href="./references#CD012044-bbs2-0072" title="SilvaV , GrandeAJ , StantonKR , PeccinMS . Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD012044] ">Silva 2016</a>) and reported <a href="#CD012044-sec-0178">Differences between protocol and review</a>. </p> <p>The limitations of the review were that too few studies were included to assess for publication bias by constructing funnel plots; poor study reporting meant that we could not assess some ‘Risk of bias’ domains; and we found an absence of participant‐centred outcome data in the included RCTs. Although the Cochrane RCT filter was adapted to Web of Science (see line #17, <a href="./appendices#CD012044-sec-0169">Appendix 4</a>) (<a href="./references#CD012044-bbs2-0051" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>), we could not find a study validation for this filter. This adaptation might introduce biases into the review process. In addition, correspondence with study investigators was incomplete. </p> <p>Additional studies may have been conducted but not yet published or published but not yet identified. Should any such studies be identified, we will include them in future updates of this review. </p> </section> <section id="CD012044-sec-0159"> <h3 class="title" id="CD012044-sec-0159">Agreements and disagreements with other studies or reviews</h3> <p>Based on our broad search strategy, this is the first systematic review investigating the effectiveness and safety of physical activity interventions for treating LUTS/BPO. The previous reviews (<a href="./references#CD012044-bbs2-0055" title="ParsonsJK , KashefiC . Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. European Urology2008;53(6):1228‐35. [DOI: 10.1016/j.eururo.2008.02.019] ">Parsons 2008</a>; <a href="./references#CD012044-bbs2-0058" title="RussoGI , CastelliT , UrzìD , PriviteraS , LaVigneraS , CondorelliRA , et al. Emerging links between non‐neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematic review. International Journal of Urology2015;22(11):982‐90. [DOI: 10.1111/iju.12877] ">Russo 2015</a>; <a href="./references#CD012044-bbs2-0060" title="SeaJ , PoonKS , McVaryKT . Review of exercise and the risk of benign prostatic hyperplasia. Physician and Sports Medicine2009;37(4):75‐83. [DOI: 10.3810/psm.2009.12.1745] ">Sea 2009</a>) only included observational studies and focused on risk factors of LUTS/BPO attributed to physical activity. Another difference was study design. We included only RCTs, while these other reviews used observational studies (e.g. cross‐sectional, case‐control, and retrospective or prospective cohort studies). There was minimal information in these other reviews regarding search strategy, assessment of risk of bias, and quality of the evidence, and no protocols were registered. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012044-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012044-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012044-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors’ judgements about each risk of bias item for each included study." data-id="CD012044-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors’ judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.1 Symptom score for LUTS." data-id="CD012044-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.1 Symptom score for LUTS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.2 Response rate." data-id="CD012044-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.2 Response rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.3 Withdrawal due to adverse events." data-id="CD012044-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Physical activity (pelvic floor exercise) as part of self management programme versus watchful waiting, outcome: 2.3 Withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Physical activity versus watchful waiting, Outcome 1 Symptom score for LUTS." data-id="CD012044-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Physical activity versus watchful waiting, Outcome 1 Symptom score for LUTS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Physical activity versus watchful waiting, Outcome 2 Response rate in symptom score." data-id="CD012044-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Physical activity versus watchful waiting, Outcome 2 Response rate in symptom score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Physical activity versus watchful waiting, Outcome 3 Withdrawal due to adverse events." data-id="CD012044-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Physical activity versus watchful waiting, Outcome 3 Withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 1 Symptom score for LUTS." data-id="CD012044-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 1 Symptom score for LUTS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-002-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 2 Response rate in symptom score." data-id="CD012044-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 2 Response rate in symptom score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-002-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 3 Withdrawal due to adverse events." data-id="CD012044-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 3 Withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 4 Change of medication use." data-id="CD012044-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 4 Change of medication use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 5 Need for an invasive procedure." data-id="CD012044-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Physical activity as part of self‐management programme versus watchful waiting, Outcome 5 Need for an invasive procedure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 1 Symptom score for LUTS." data-id="CD012044-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 1 Symptom score for LUTS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 2 Response rate in symptom score." data-id="CD012044-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 2 Response rate in symptom score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 3 Withdrawal due to adverse events." data-id="CD012044-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 3 Withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 4 Postvoid residual urine." data-id="CD012044-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Physical activity as part of weight reduction programme versus watchful waiting, Outcome 4 Postvoid residual urine. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Physical activity compared to alpha‐blockers, Outcome 1 Symptom score for LUTS." data-id="CD012044-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Physical activity compared to alpha‐blockers, Outcome 1 Symptom score for LUTS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Physical activity compared to alpha‐blockers, Outcome 2 Response rate in symptom score." data-id="CD012044-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Physical activity compared to alpha‐blockers, Outcome 2 Response rate in symptom score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012044-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/urn:x-wiley:14651858:media:CD012044:CD012044-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_t/tCD012044-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Physical activity compared to alpha‐blockers, Outcome 3 Withdrawal due to adverse events." data-id="CD012044-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Physical activity compared to alpha‐blockers, Outcome 3 Withdrawal due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/media/CDSR/CD012044/image_n/nCD012044-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012044-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Physical activity compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (tai chi and pelvic floor exercise) </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was 17.1 (95% CI 11.9 to 22.3).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 8.1 lower<br/> (13.2 lower to 3.9 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 4 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.80<br/> (0.81 to 4.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>357 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>286 more per 1000<br/> (68 fewer to 1000 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b> </p> <p>Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>56<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.59 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 fewer per 1000<br/> (205 fewer to 345 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); blinding of participants and personnel (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>); incomplete outcome data (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); other bias (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>2</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; <a href="./references#CD012044-bbs2-0005" title="WengWC , TsengHJ , ChangJC , WangCY , SuCM . The effects of pelvic floor muscle exercise for irritable symptoms in older men with luts suggestive of bph. International Journal of Urology2010;17(Suppl 1):A185. ">Weng 2010</a>).<br/> <sup>3</sup>Downgraded for imprecision (‐1): wide confidence interval; small sample size; low event rates—only one small study (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>; n = 28) contributed with data and analyses.<br/> <sup>4</sup>Dowgraded for imprecision (‐1): wide confidence interval; small sample size; low event rates.<br/> <sup>5</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); incomplete outcome data (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>); other bias (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>6</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0004" title="JungS , LeeE‐N , LeeS‐R , KimM‐S , LeeMS . Tai chi for lower urinary tract symptoms and quality of life in elderly patients with benign prostate hypertrophy: a randomised controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;2012:624692. [DOI: 10.1155/2012/624692] ">Jung 2012</a>).<br/> <sup>7</sup>Dowgraded for imprecision (‐1): small sample size; low event rates. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Physical activity compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012044-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Physical activity as part of self‐management programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (pelvic floor exercise) as part of self‐management programme </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity as part of self‐management programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b> </p> <p>Assessed with: IPSS<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS by IPSS was 17.8 (95% CI 16.7 to 18.8).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 6.2 lower<br/> (9.9 lower to 2.5 lower) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b> </p> <p>Assessed with: frequency<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 3 4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.36<br/> (1.32 to 4.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>312 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>424 more per 1000<br/> (100 more to 1000 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b> </p> <p>Assessed with: frequency<br/> Follow‐up: range 6 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>362<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3 6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65 fewer per 1000<br/> (65 fewer to 65 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); blinding of participants and personnel (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>; <a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>); blinding of outcome assessment (<a href="./references#CD012044-bbs2-0002" title="ChenY , ZhangX , HuX , DengY , ChenJ , LiS , et al. The potential role of a self‐management intervention for benign prostate hyperplasia. Urology2012;79(6):1385‐8. [DOI: 10.1016/j.urology.2011.11.091] ">Chen 2012</a>); selective reporting (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); other bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>).<br/> <sup>2</sup>Downgraded for inconsistency (‐1): variation in point estimates; confidence intervals do not overlap; heterogeneity (I<sup>2</sup> = 87%; P = 0.005).<br/> <sup>3</sup>Downgraded for indirectness (‐1): pelvic floor exercise was one component of a complex intervention, thus we cannot attribute the effect to physical activity alone.<br/> <sup>4</sup>Dowgraded for imprecision (‐1): wide confidence interval; low event rates.<br/> <sup>5</sup>Downgraded for inconsistency (‐1): variation in point estimates; heterogeneity (I<sup>2</sup> = 83%; P = 0.01).<br/> <sup>6</sup>Downgraded for study limitations (‐1): high risk of bias: allocation concealment (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); selective reporting (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>); other bias (<a href="./references#CD012044-bbs2-0001" title="BrownCT , EmbertonM . Self‐management for men with lower urinary tract symptoms. Current Urology Reports2009;10(4):261‐6. [DOI: 10.1007/s11934‐009‐0043‐6] BrownCT , YapT , CromwellDA , RixonL , SteedL , MulliganK , et al. Self management for men with lower urinary tract symptoms: randomised controlled trial. BMJ2007;334(7583):25. [DOI: 10.1136/bmj.39010.551319.AE; Erratum in: BMJ 2007;335(7617):0‐f; For full information see html version in: www.bmj.com/content/334/7583/25] NCT00270309 . Self‐management for men with uncomplicated lower urinary tract symptoms. clinicaltrials.gov/ct2/show/NCT00270309 (first received 26 December 2005). YapTL , BrownC , CromwellDA , van derMeulenJ , EmbertonM . The impact of self‐management of lower urinary tract symptoms on frequency‐volume chart measures. BJU International2009;104(8):1104‐8. [DOI: 10.1111/j.1464‐410X.2009.08497.x] ">Brown 2007</a>).<br/> <sup>7</sup>Downgraded for imprecision (‐1): low event rates. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Physical activity as part of self‐management programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012044-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Physical activity as part of weight reduction programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (intense exercise) as part of weight reduction programme </p> <p><b>Comparison:</b> watchful waiting </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with watchful waiting</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity as part of weight reduction programme</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 48 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was ‐0.7 (95% CI ‐2.4 to 1.0).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 1.1 lower<br/> (3.5 lower to 1.3 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 48 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>117<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.20<br/> (0.74 to 1.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67 more per 1000<br/> (87 fewer to 313 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b><br/> Assessed with: frequency </p> <p>Follow‐up: 48 weeks</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>130<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2 3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.63<br/> (1.03 to 2.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>184 more per 1000<br/> (9 more to 459 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>): blinding of participants and personnel; incomplete outcome data; selective reporting; other bias.<br/> <sup>2</sup>Downgraded for indirectness (‐2): physical activity was one component of a complex intervention; thus we cannot attribute the effect to physical activity alone; the intervention was described as "intense exercise", but there was insufficient information regarding type, frequency, and duration of physical activity.<br/> <sup>3</sup>Dowgraded for imprecision (‐1): low event rates.<br/> <sup>4</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0006" title="YeeCH , SoWY , YipSK , WuE , YauP , NgCF . Effect of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia: a randomized controlled trial. Korean Journal of Urology2015;56(3):240‐6. [DOI: 10.4111/kju.2015.56.3.240] ">Yee 2015</a>): incomplete outcome data; selective reporting; other bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Physical activity as part of weight reduction programme compared to watchful waiting for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012044-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Physical activity compared to alpha‐blockers for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> men with lower urinary tract symptoms secondary to benign prostatic obstruction </p> <p><b>Intervention:</b> physical activity (pelvic floor exercise) </p> <p><b>Comparison:</b> alpha‐blockers (tamsulosin 0.4 mg/day) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with alpha‐blockers</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with physical activity</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptom score for LUTS</b><br/> Assessed with: IPSS<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The mean change in symptom score for LUTS was 8.8 (95% CI 5.9 to 11.7).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.8 higher<br/> (0.9 lower to 6.4 higher) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Response rate</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>39<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.80<br/> (0.55 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>833 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>167 fewer per 1000<br/> (375 fewer to 125 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Withdrawal due to adverse events</b><br/> Assessed with: frequency<br/> Follow‐up: 3 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>41<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.86<br/> (0.06 to 12.89) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 fewer per 1000<br/> (49 fewer to 626 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>IPSS:</b> International Prostate Symptom Score; <b>LUTS:</b> lower urinary tract symptoms; <b>MD:</b> mean difference; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded for study limitations (‐1): high risk of bias (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>): blinding of participants and personnel; blinding of outcome assessment; selective reporting.<br/> <sup>2</sup>Downgraded for indirectness (‐1): outcome time frame insufficient (<a href="./references#CD012044-bbs2-0003" title="DekkerJH , Van derHeideW , MesselinkB , Van derHeideCJ , BlankerM , BergerM . Pelvic floor muscle therapy compared to treatment with alpha‐1 blocking agents for lower urinary tract symptoms in older men in primary care. ICS 2012; 2012 Oct 15‐19; Beijing. International Continence Society, 2012. [Abstract 434; www.ics.org/2012/abstract/434] HutJ . Pelvic Floor Exercises Compared to Medication in the Treatment of Older Men with Lower Urinary Tract Symptoms in General Practice. The FLOW Study. A Pilot [Master's thesis]. Groningen (NL): The University of Groningen, 2011. [File for downloading: scripties.umcg.eldoc.ub.rug.nl/FILES/root/geneeskunde/2011/HutJ/HutJ.docx; Full record and abstract: scripties.umcg.eldoc.ub.rug.nl/root/geneeskunde/2011/HutJ/?pFullItemRecord=ON] HutJ , van derHeideWK , KollenBJ , MesselinkEJ , BlankerMH , DekkerJH . Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: an exploratory randomized controlled trial. International Journal of Urology2017;24(6):473–4. [DOI: 10.1111/iju.13339] NTR2954 . Lower urinary tract symptoms (LUTS) in older men. The FLOW study. www.trialregister.nl/trialreg/admin/rctview.asp?TC=2954 (first received 28 June 2011). ">Hut 2016</a>).<br/> <sup>3</sup>Dowgraded for imprecision (‐1): small sample size; low event rates. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Physical activity compared to alpha‐blockers for lower urinary tract symptoms secondary to benign prostatic obstruction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/full#CD012044-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012044-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Physical activity versus watchful waiting</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptom score for LUTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.14 [‐13.20, ‐3.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Response rate in symptom score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.8 [0.81, 4.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.59, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Physical activity versus watchful waiting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012044-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Physical activity as part of self‐management programme versus watchful waiting</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptom score for LUTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.16 [‐9.85, ‐2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.97 [‐9.52, ‐6.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐6.31, ‐2.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Response rate in symptom score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.36 [1.32, 4.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.16 [2.24, 4.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [1.28, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>362</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.05, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.02, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.10, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change of medication use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.10, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.15, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.25, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for an invasive procedure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Short term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Medium term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Long term</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.03, 2.87]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Physical activity as part of self‐management programme versus watchful waiting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012044-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Physical activity as part of weight reduction programme versus watchful waiting</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptom score for LUTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.1 [‐3.46, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Response rate in symptom score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.74, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.03, 2.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postvoid residual urine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐25.0 [‐54.73, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Physical activity as part of weight reduction programme versus watchful waiting</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012044-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Physical activity compared to alpha‐blockers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Symptom score for LUTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.75 [‐0.93, 6.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Response rate in symptom score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.55, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Withdrawal due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.06, 12.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Physical activity compared to alpha‐blockers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012044.pub2/references#CD012044-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012044.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012044-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012044-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012044-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012044-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012044-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012044-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012044-note-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012044-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012044\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012044\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012044\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012044\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012044\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012044.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012044.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012044.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012044.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012044.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727409895"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012044.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727409899"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012044.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eab5d9eb49377',t:'MTc0MDcyNzQxMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 